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ABSTRACT
CHARACTERIZATION OF THE INTERACTION BETWEEN UPF1 AND PAJB1 
& THE IDENTIFICATION AND CHARACTERIZATION OF COMPLEXES 
ASSOCIATED WITH TRANSLATION TERMINATION FACTOR ERFl
By
Roy Richardson 
University o f New Hampshire, September 2013 
There are still many protein interactions that occur during translation 
termination that are poorly understood. One of the important termination pathways 
still under investigation is nonsense-mediated decay (NMD), which rapidly degrades 
mRNAs that contain a premature stop codon (PTC). I identified that the interaction 
between Upfl, which is required for NMD, and PAB1 occurs via the RRM1 domain 
of PAB1 in the yeast Saccharomyces cerevisiae. Determining the role of this 
interaction during NMD was performed with pulse-chase assays using a PGKlpG  
mRNA. These assays revealed that the interaction between Upfl and PAB1 is 
required for a shift from distributive to processive deadenylation, but is not required 
for decapping or general decay during NMD. These results also revealed that this 
interaction plays a role in the normal shift in deadenylation mode for non-PTC 
containing mRNAs from the relatively slow mode of distributive deadenylation to 
that of rapid processive deadenylation.
I also investigated the components of general termination complexes 
associated with the translation termination factor eR F l. This analysis was performed
using the novel technique of analytical ultracentrifugation with a fluorescence 
detection system (AU-FDS) on Flag-eRFl affinity purified extracts. AU-FDS 
revealed that Flag-eRFl associates with six distinct complexes that have S values of 
20S, 28S, 39S, 57S, 77S, as well as complexes greater than 100S. All o f these 
complexes contained the closed-loop components eIF4E, eIF4Gl, and PAB1. 
However, stoichiometric analysis revealed that the complexes greater than 28S were 
comprised mostly of free ribosomal subunits associated with eR F l. Glucose 
deprivation and cycloheximide stress treatments revealed that these complexes are 
likely post-termination complexes rather than pre-initiation or translationally active 
complexes.
Additional observations from AU-FDS revealed a shifting behavior for the 
20S complex during sedimentation, suggesting a shift in shape or composition during 
the experiment. Also, the abundance and sedimentation profile o f eRF3 suggests that 
it forms a polymer-like structure consistent with a known eRF3 prion characteristic.
These analyses further reveal the interactions involved in the termination 
process. The application of AU-FDS continues to prove a useful tool for identifying 
novel protein complexes.
GENERAL INTRODUCTION AND BACKGROUND
Introduction
Deciphering the protein complexes and interactions during various stages of 
eukaryotic translation remains one of the major quests of current biology. These 
characterizations will inform all aspects of protein synthesis and regulation in cellular 
systems. This thesis aims to investigate two aspects o f protein interactions during the 
termination stage of translation. The first is to investigate the interactions involved in the 
process of nonsense-mediated decay. In particular, these studies involved investigating 
the interaction between the proteins UPF1 and PAB1 and the role o f this interaction 
during nonsense-mediated decay. The second focus is to explore the protein complexes 
that interact with the termination factor eRFl, and specifically, to utilize analytical 
ultracentrifugation with a fluorescence detection system to identify complexes associated 
with eRFl.
Eukaryotic Translation
Regulation of protein synthesis can occur by suppressing or stimulating many 
regulatory steps, including those of transcription or translation. Regulation of messenger 
RNAs (mRNAs) at the translational level can result in more rapid effects on protein 
levels than effects at the transcriptional level. There are four main stages o f translation: 
initiation, elongation, termination, and ribosome recycling, each characterized by their 
individual mechanisms of regulation.
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In the cytoplasm, mRNAs exist as a complex of mRNA and proteins called a 
messenger ribonucleoprotein (mRNP) complex. One of the most abundant mRNP 
complexes in the yeast Saccharomyces cerevisiae is the translationally active complex, 
but a number of such complexes exist (Richardson et a l,  2012; Mitchell et a l ,  2013).
Translation Initiation
Translational initiation in the cytoplasm begins with the formation of the ternary 
complex, which consists of a Met-tRNAi and initiation factor eIF2-GTP. The Met-tRNAi 
interacts with the 40S subunit of the ribosome via the P site (Rabl et a l , 2011). The 
initiation factors elF l, 1 A, 3 and 5 also interact with the 40S subunit to form the 43 S pre­
initiation complex (Figure 1) (Asano et a l,  2000; Hinnebusch et al., 2011). This complex 
can interact with the closed loop mRNP structure.
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Figure 1: Eukaryotic pre-initiation complex formation and translation initiation. Hinnebusch, 2011
The core protein components o f the closed loop mRNP complex are PAB1 (poly- 
A RNA binding protein), eIF4E (cap binding protein), and eIF4G (the bridging protein). 
P AB1 binds to the poly( A) tail o f the mRNA (requiring about 25 adenosine residues per 
PAB1) and eIF4E binds the 5’ cap with eIF4G interacting with both PAB1 and eIF4E, 
creating a closed loop structure (Figure 2) (Deo et al., 1999). PAB1 must be on the 
poly(A) tail to interact with eIF4G (Wells et al. , 1998). This complex also contains the 
translation initiation factors eIF4A and eIF4B, which are required for the 43S complex to 
bind and begin scanning for the start codon.
Figure 2: The translationally active yeast mRNP complex highlighting the closed loop structure 
interactions. Gallie, D, University o f  California, Riverside.
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The 43 S complex is aided in its interaction with the closed structure via the 
hydrolysis of ATP by eIF4A, thereby creating the 48S pre-initiation complex (Pisarev et 
al., 2007a). The 48S complex travels along the 5’ untranslated region (UTR), in a process 
known as the scanning mechanism, until it reaches and forms a stable base pairing with 
the AUG start codon (Hinnebusch AG, 2011). This process is assisted by the helicase 
activity of eIF4A (Spirin AS, 2009).
Once the Met-tRNAi forms a stable pairing with the start codon the pre-initiation 
complex is joined by the 60S subunit o f the ribosome following the hydrolysis of GTP by 
eIF2 via the GTPase activating initiation factor eIF5B (Pisarev et al., 2007a). Once the 
60S subunit joins the elongation stage of translation begins, and it is believed that 
following eIF2 GTP hydrolysis the initiation factor eIF2-GDP disassociates from the 
mRNP complex to form a new pre-initiation complex via the phosphorylation of eIF2- 
GDP by eIF2B.
Translation Termination
Translational termination occurs when the ribosome reaches a stop codon.-At this 
point termination factor eRFl interacts with the stop codon more tightly than any tRNA 
does at the A site (Conard et a l, 2012). The termination factor eRF3 then interacts with 
eRFl and upon hydrolysis o f GTP causes eRFl to release the peptide chain, although the 







Figure 3: Termination and peptide release via eRFl/eRF3. Keeling & Bedwell, 2011.
After termination ribosome recycling can occur if the mRNP does not enter a 
degradation pathway. The separation of the ribosomal subunits by ribosomal recycling 
factors (RRFs) in conjunction with elongation factor G (EF-G) in prokaryotes does not 
have a conserved eukaryotic equivalent (Hirokawa et al., 2005; Hirokawa et al., 2006). 
The mechanism of ribosome recycling in eukaryotes is not understood, but it is dependent 
on the ATPase ABCE1 (Rlil in yeast) (Pisarev et a l,  2010). It has also been determined 
that the initiation factor eIF3 is primarily responsible for splitting the post-termination 
subunits of the ribosome (Pisarev et a l,  2007b). Kinetic analysis suggests that the Rlil 
dependency relies on an interaction with eRFl and eRF3 (Shoemaker & Green, 2011).
Post Termination Degradation
The major degradation pathway of the mRNP complex requires the mRNA to be 
deadenylated by the cytoplasmic deadenylase, CCR4, after PAB1 has left the poly(A) tail 
(Denis and Chen, 2003). The DCP1/2 complex decaps the mRNA after it has been 
deadenylated to about 8 - 1 2  adenosine residues (Muhlrad and Parker, 1994). The mRNA 
is then degraded 5’ to 3’ by the exonuclease Xmlp  (Muhlrad and Parker, 1994). This
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decay process occurs in P bodies (Sheth and Parker, 2003). A P body consists of mRNP 
aggregations along with proteins involved in mRNA decay and translational repression. If 
an mRNA contains a premature termination codon (PTC), it will also be targeted to a P 
body for degradation. However, in this case the mRNA is degraded much more rapidly 
than its wild type form to prevent the translation of a truncated protein. This degradation 
pathway is referred to as nonsense-mediated decay (NMD).
Translationally silent mRNPs in P bodies are not always degraded. Some silenced 
mRNPs, repressed under stress conditions, are reactivated and returned to polysomes 
when the stressor is removed (Brengues, Teixeira, and Parker, 2005). Complexes that are 
silenced due to specific stress conditions, such as glucose deprivation, aggregate in 
unique complexes called stress granules. Glucose deprived stress granules are known to 
contain eIF4E, eIF4G, PAB1, as well as mRNA and their formation is dependent on P 
body formation (Buchan, Muhlrad, and Parker, 2008). Additional related types of stress 
granules are formed following robust heat shock (at 46°C). These latter stress granules 
contain the above stress granule components as well as the 40S ribosomal subunit and 
initiation factors such as eIF3 (Grousl et al., 2009). These differences in stress granule 
composition have been related to different stages in blocking initiation by the different 
stress conditions (Wang et al., 2012).
7
PAB1
The protein PAB1 plays an integral role in mRNP complex stability. PAB1 is a 
poly(A)-binding protein that has high affinity for poly adenosine residues but can also 
bind to AU mixed regions. It consists o f four non-identical RNA recognition motif 
domains (RRMs), a proline rich loose coil region (P domain), and a C-terminal domain 
(Figure 4). Deletion of PAB1 is a lethal mutation in yeast (Wyers et al., 2000). The 
domains RRM1 and RRM2 interact with poly(A) sequences tightly, however RRM3 and 
RRM4 can also interact with poly(A) sequences as well as possibly allowing for the 
interaction with U-rich sequences adjacent to the poly(A) tail (Deardorff and Sachs, 
1997; Deo et al., 1999; Mullin et al., 2004; Sladic et al., 2004). RRM1 has also been 
shown to interact with UPF1, causing a shift from distributive to processive 
deadenylation during NMD (Richardson et al., 2012). RRM2 has been shown to be 
required for functionally interacting with eIF4G, strengthening the circular complex and 
being required for poly(A) tail-dependent translation (Kessler and Sachs, 1998). The P- 
domain is required for CCR4 deadenylation and along with the C domain interacts with 
eRF3 in yeast, which increases the efficiency of termination (Yao et al., 2007; Cosson et 
al., 2002; Richardson et al., 2012).
PAB1 also regulates the length of the poly(A) tail. It assists in controlling tail 
length during mRNA synthesis as well as when deadenylation is initiated (Minvielle- 
Sebastia et al., 1997; Brown et al., 1998). An interaction between PAB1 and 
PAN2/PAN3 is required to initiate tail trimming (Brown et al., 1996). To initiate mRNA 
degradation, PAB1 must leave the poly(A) tail before CCR4 can access the adenosine
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residues and deadenylation can begin. RRM1 and the RRM4 domain have been shown to 
interact, forming a circular form of PAB1 itself that is believed to promote the 
dissociation of PAB 1 from the poly(A) tail (Yao et a l, 2007).
^  R R M I ^  ^ R R M 2 ^  ( W ) - Q   - - - - - - C  )  
Figure 4: A simplified diagram o f  P A B l’s domains. The N  terminal end is on the left side o f  the figure.
Nonsense-Mediated Decay
During NMD, decapping and deadenylation occur independently o f one another 
(Cao and Parker, 2003). This means that the disassociation of PAB 1 is not required for 
NMD since the mRNA can still be decapped and degraded 5’ to 3’ prior to deadenylation 
(Meaux, van Hoof, and Baker, 20Q8). Substrates for NMD are targeted by the RNA 
binding and RNA-dependent ATPase and helicase, UPF1. UPF1 is required for NMD and 
PTC containing mRNAs will have a half-life similar to their normal counterparts in a 
Aupfl strain (Leeds et al., 1991; Cao and Parker, 2003). UPF1 interacts with UPF2 and 
UPF3 with UPF2 linking UPF1 and UPF3, creating a surveillance complex (He, Brown, 
and Jacobson, 1997). UPF2 and UPF3 are also present in P bodies and mutating either of 
these has similar effects as mutating UPF1, although each has their own role in NMD 
(He, Brown, and Jacobson, 1997). UPF1 has been shown to aggregate in P bodies in 
Adcpl, Adcp2, Aepf2, Aup/3, and Axrnl strains as well as when its ATPase activity is 
inhibited (Sheth and Parker, 2006).
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UPF1 accumulates in P bodies when its ATPase activity is inhibited by two 
sequential point mutations, D572E573-»A 572A573 (Weng, Czaplinski, and Peltz, 1996). 
When this ATPase defective form of UPF1 (UPF1-AD) is over expressed it causes the 
accumulation of DCP2-GFP in P bodies, which does not occur with UPFl-wt 
overexpression. Overexpression of UPF1-AD also increases the abundance of a PTC 
containing PGK1 mRNA in P bodies compared to UPFl-wt, showing that the ATPase 
activity o f UPF1 is not required for targeting NMD substrates to P bodies. These results 
indicate that UPF1-AD targets NMD substrates but does not trigger decapping (Sheth and 
Parker, 2006). This form of UPF1 may trigger the formation of a translationally silent 
mRNP complex that is ready for degradation upon ATP hydrolysis.
There is also a polar effect in NMD in which candidate mRNAs with earlier PTCs 
are degraded faster than those with a PTC later in the coding sequence (Cao and Parker, 
2003). One model that explains this phenomenon suggests that a downstream sequence 
element (DSE) 3’ of the PTC is used to distinguish a normal termination codon from a 
premature one (Zhang et al., 1995). HRP1, for example, has been identified as a protein 
that interacts specifically to a DSE-containing mRNA as well as interacts with UPFl. 
Furthermore, a mutation that prevents HRP1 from interacting with UPF1 stabilizes NMD 
substrate mRNAs without affecting normal mRNAs (Gonzalez et al., 2000). HRP1 is 
likely to be in the translationally silent mRNP complex, possibly signaling UPF1 to 
localize the mRNA in a P body for destruction. Two other candidate proteins involved in 
this process, both found in P bodies, and may be present in the silent mRNP complex are 
RBP1 and SBP1. SBP1 is an RNA binding protein that promotes decapping. RBP1 is
10
also an RNA binding protein and has been found to localize to P body complexes under 




One of the principal foci o f this thesis was to determine the protein complexes in 
which eRFl is involved. Mass spectrometric analysis and in vitro studies indicate that 
termination factors eRFl and eRF3 interact with PAB1 as well as the P-site o f the 80S 
ribosome (Richardson et al., 2012; Cosson et a l,  2002; Taylor et a l ,  2012). Although 
methods such as sucrose gradient analysis and chromatography can be used to determine 
the components and sizes o f protein complexes, the low abundance and small size of 
complexes associated with eRFl make such methods difficult. Based on the sensitivity 
and success of using analytical ultracentrifugation with a fluorescence detection system 
(AU-FDS) with a Flag-tagged bait and GFP-tagged target system to identify novel 
protein complexes that interact with RPL25A and PAB1, the AU-FDS method was 
ultimately used to identify novel complexes that associate with eRFl (Wang et a l,  2012).
Analytical Ultracentrifugation
Analytical ultracentrifugation (AU) has been widely used for some time to 
determine the molecular weight (MW) of biological molecules (Cole et a l,  2008). AU 
relies on measuring the rate, or sedimentation velocity, o f the target molecule as it travels 
through a solution. Using this information and the analytical software Sedfit AU, one can 
determine the sedimentation coefficient o f the target molecule as long as the buffer
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density, the viscosity, and amount o f centrifugal force are known (Schuck, 2000). The 
sedimentation coefficient is formulated by the ratio of the sedimentary boundary to the 
centrifugal force and is represented by the Svedberg unit (S value) (Equation 1). The S 
value has units of time since it measures the rate o f movement in solution where
value for a given centrifugal force. S values are standardized to the sedimentation rate in 
water at 20°C (S2o,w)- Conversion of the experimental S value to the standard is done by 
using a conversion equation, with the density and viscosity of the experimental buffer 
determined by the software Sednterp (Equation 2) (Laue et al., 1992). The MW of the 
target can only be approximated since the shape o f the target must be assumed (Equation 
3). Targets that have a 2-3 length to width ratio have an S value that is 1.4-fold smaller 
than a spherical target of equal mass due to a change in the frictional coefficient.
IS = 10'13s. The mass, density, and shape of the target molecule all contribute to the S
N J  RT
Equation 1: The Svedberg equation
Equation 2: Svedberg conversion equation, where v =  v bar, p = density, r| = viscosity
Equation 3: Molecular weight determination equation assuming a spherical globular shape.
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There are many advantages to using AU analysis compared to other techniques to 
determine protein complex sizes such as that of sucrose gradient analysis or 
chromatography. AU can provide more accurate approximations o f complex size than 
sucrose gradients by tracking a target molecule in real time as it moves through solution 
during centrifugation. Sucrose gradients can only provide a single snap shot of the 
position of the molecule whereas AU analysis takes a series o f snap shots over time. 
Utilizing multiple scans as the target moves also provides higher resolution in size 
profiling than chromatography. Furthermore, AU can be performed in a biologically 
relevant buffer with much more flexibility in regards to the density and composition o f 
the buffer solution, which allows for the characterization of the target in its native state. 
AU is also much more sensitive than sucrose gradient or chromatography techniques, 
requiring as little as 100 pM concentration of the target molecule for detection (Cole et 
al., 2008). Importantly, AU does not require a secondary detection method to determine 
the presence or size o f its targets, such as Western analysis, which is time consuming and 
is restricted to analysis of just fifteen or so slices across a sucrose gradient MW 
continuum. In contrast, AU analysis can analyze hundreds o f slices across the MW 
continuum, providing an order o f magnitude greater resolution compared to standard 
sucrose gradient or chromatographic analysis.
AU can also be used to track multiple targets in solutions, providing a size 
distribution of targets (Schuck et al., 2002). The target molecules can be tracked using 
either an absorbance or fluorescence detection system (MacGregor et al., 2004; Cole et 
al., 2008). Complexes comprised of protein and nucleic acids can be identified at 230 nm
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or 260 nm, respectively, using the absorbance detection system. AU-FDS can track a 
protein that has been fused with green fluorescent protein (GFP) and excited it at 488 nm 
(Cole et a l, 2008). Using a GFP-fused protein allows a specific protein to be identified 
using the FDS rather than tracking all proteins present using absorbance.
By using a Flag-tagged protein and using Flag-bead affinity purification in 
conjunction with an individual GFP tagged protein, protein complexes can be identified 
with AU-FDS (Wang et a l,  2012). Using a Flag-tagged PAB1 or RPL25A protein in 
conjunction with various mRNP components fused with GFP, a 77S complex was 
identified as the monosomal translating complex using AU-FDS (Wang et a l,  2012).
This complex was repressed under various stress responses, and the interactions 
responsible for various stress granule formations under varying stress conditions were 
elucidated. Subsequent studies have verified the utility of AU-FDS analysis for studying 
translation complexes (Zhang et al., 2013).
Thesis Project
The first part of my thesis project was to investigate the interaction between UPF1 
and PAB1 and the role of this interaction on NMD. UPF1 was identified as one o f many 
proteins found to interact with PAB1 by using mass spectrometry (Richardson et a l, 
2012). The site of interaction was suggested to be the RRM1 domain of PAB1. Deletion 
analysis, immuno-precipitation, and western blotting was used to confirm this. 
Deadenylation assays further demonstrated that NMD can occur independently o f PAB1 
leaving the poly(A) tail and also revealed that the interaction between UPF1 and the
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RRM1 domain of PAB1 plays a role in transitioning mRNA degradation from 
distributive to processive deadenylation under normal conditions.
For the second part of this thesis project I used Flag affinity purification using 
Flag-eRFl as a bait to identify translation related complexes containing eR F l. AU-FDS 
analysis was performed on these Flag-purified complexes. A 77S complex different from 
the one identified previously by our lab was detected (Wang et al., 2012). The 77S 
complex associated with eRFl does not change in abundance in response to various stress 
conditions, unlike the 77S complex identified using Flag-PABl and RPL25A-Flag. A 
39S and 57S complex was also visualized similar to previous analysis (Wang et al., 2012; 
X. Wang pers. comm.). Importantly, previously unknown protein complexes in the 10S- 
3 OS regions were identified as well as monomer GFP-fused targets. The character and 
stoichiometry of all o f these eRFl-containing complexes was determined. Moreover, 
analyses of increasing scan fits indicate that protein complexes in the 10S-30S regions 
represent a reaction boundary rather than a single sedimentation boundary. This is 
characterized by a shift in S position of the peaks in this region as the number o f scans 
increases whereas peaks greater than 30S and less than 10S do not shift in position. This 
suggests that the complexes sedimenting in the 10S-30S regions are changing size as the 
sedimentation experiment proceeds. These peaks no longer shift after 500 scans 




THE INTERACTION BETWEEN UPF1 AND PAB1 IS NOT REQUIRED FOR 
NONSENSE-MEDIATED DECAY, BUT DOES PLAY A ROLE IN THE SHIFT 
FROM DISTRIBUTIVE TO PROCESSIVE DEADENYLATION
Introduction
The investigation of proteins that associate with PAB1 utilizing mass 
spectrometry revealed that the UPF1 was one of the proteins that associated with the 
RRM1 domain of PAB 1 (Richardson et al, 2012; see Appendix I). UPF1 is the core 
component of the mRNA surveillance complex (comprised of UPF1, UPF2, and UPF3), 
which initiates the rapid decay of mRNA containing premature termination codons 
(PTCs), known as nonsense-mediated decay (NMD) (Leeds et a l , 1991). Western blots 
utilizing Flag-PABl and HA-UPF1 verified that the interaction between the two proteins 
occurred via the RRM1 domain and not through the other domains o f PAB 1 (Richardson 
et a l,  2012; Appendix I). Deadenylation assays were performed to further investigate the 
role of the interaction between UPF1 and the RRM1 domain of PAB 1 on mRNA decay. 
These assays revealed that the interaction between UPF1 and the RRM1 domain was 
required to shift deadenylation from a distributive to a processive mode but was not 
required for decapping or decay in general. In addition, the interaction between UPF1 and 
RRM1 was also shown to play a role in this shift in deadenylation mode for non-PTC 
containing mRNAs.
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It would be expected that an interaction between the RRM1 domain and UPF1 
would play an important physiological role in NMD. However, deletion of PAB 1 does 
not prevent the process of UPF1-mediated NMD (Meaux et a l,  2008). UPF1-mediated 
decay involves both decapping and deadenylation occurring independent of one another, 
which are both accelerated, with decapping as the major pathway (Cao and Parker, 2003). 
The deletion of RRM1 in PAB1 has been shown to have no effect on decapping but was 
found to be necessary for deadenylation (Yao et al., 2007; Lee et a l ,  2010; Simon and 
Seraphin, 2007). Therefore, PAB1 possibly plays a role in the deadenylation process o f 
NMD.
M aterials and Methods (see Appendix I)
Results
Pulse-chase assays were performed to determine the role o f the RRM1 domain on 
the NMD process. GAL1-PGK1 mRNA that was either wt or contained a PTC at residue 
319 was used. The PTC at residue 319 was previously shown to be an NMD candidate 
(Cao and Parker, 2003). The isogenic yeast strains containing Flag-PABl or Flag-PABl- 
ARRM1 with GALl-PGKlpG  or GAL1 -PGKlpG-319 were grown in galactose and 
glucose free media. The GAL1 promoter was briefly induced with galactose and 
subsequently shut off with glucose. Samples were taken over time after transcription was 
shut off and rapidly frozen prior to RNA purification. Northern blot analysis was 
performed on the RNA extractions to identify PGK1 mRNA as a function of time.
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Analysis of the PAB1 wild-type with wild-type PG KlpG  mRNA showed a shift 
in distributive to processive deadenylation as the poly(A) tail reached a reduction point of 
about 10 A’s (Appendix I, Figure 4A). This is also when the decapped fragment appears 
and becomes more abundant over time. The PTC containing PG KlpG  mRNA displayed 
much more rapid decapping and deadenylation, as expected (Appendix I, Figure 4C; Cao 
and Parker, 2003). The deadenylated and decapped mRNA fragment appears immediately 
in much greater abundance than any time point in the wild-type PGK1 analysis. 
Additionally, the band of deadenylating PGKlpG-319 mRNAs is much broader from the 
initial time point, indicating that processive deadenylation is occurring more rapidly than 
with wild-type PGKlpG.
Analysis of the PGKlpG  and PGKlpG-319 mRNAs in a ARRM1 PAB1 strain 
compared to the wild-type PAB1 data revealed that deleting RRM1 blocked the 
deadenylation process for both mRNAs (Appendix I, Figures 4B & 4D). For wild-type 
PGKlpG  no fragment appeared, which is consistent with deadenylation dependent 
decapping (Decker and Parker, 1993). For the PGKlpG-319 mRNA, there is little 
apparent deadenylation. However, a decapped, but not deadenylated, fragment appeared 
very rapidly. This indicates that RRM1 is not required for the decapping of PTC 
containing mRNAs, but it is required for the acceleration of NMD deadenylation.
Since deleting RRM1 prevents PAB1 from leaving the poly(A) tail, its contact 
with UPF1 may not play a role in the deadenylation inhibition effect. To test this, the 
same pulse-chase assay experiments as described above were performed in an isogenic
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Aupfl background. For PGKlpG  mRNA, deadenylation rates occurred at the same rate as 
previously observed (Appendix I, Figures 5A & 5B). However, the banding pattern was 
tight throughout the assay, indicating that a shift from distributive to processive 
deadenylation did not occur. This suggests that UPF1 plays a role in the switch from 
distributive to processive deadenylation under normal conditions, a process which 
requires the removal of PAB 1 from the poly(A) tail (Tucker et a l ,  2002, Viswanathan et 
al., 2003, Yao et a l, 2007). Also, fewer deadenylated fragments were seen, which is 
consistent with this observation.
For NMD with Aupfl, PGKlpG-319 mRNA was deadenylated similarly to wild- 
type PGK1 mRNA, since UPF1 is required for NMD deadenylation (Appendix I, Figures 
5C & 5D). Little to no fragment was observed and a shift to processive deadenylation did 
not occur. PGKlpG  and PGKlpG-319 mRNA deadenylation was blocked by the deletion 
of RRM1 in the background strains, indicating that the RRM1 requirement for 




We established that deletion of the RRM1 domain of PAB 1 blocked NMD 
deadenylation but had no effect on the decapping step of NMD, which agrees with the 
results that indicate that PAB1 is not required for NMD (Meaux et a l,  2008). However, 
since this deletion blocks deadenylation in a Aupfl background as well, it cannot be 
concluded that the interaction between RRM1 and UPF1 has a specific role in NMD.
Further analysis of the pulse-chase data revealed that the role for this interaction 
may be in the transition from distributive to processive deadenylation. This observation is 
supported by three observations. First, the deletion of UPF1 prevents a shift to processive 
deadenylation for PGK1 mRNA. Second, the removal of PAB 1 from the poly(A) tail is 
required for this shift and deletion of RRM1 blocks PAB1 from leaving the mRNA (Yao 
et a l, 2007). Third, during NMD UPF1 is required for the observed rapid processive 
deadenylation. These observations support the model that UPF1 accelerates 
deadenylation during NMD via an interaction with RRM1 and accelerating the removal 
o f PAB 1 from the poly(A) tail. They also support a role for UPF1 in the transition from 
distributive to processive deadenylation in normal mRNA degradation. For a more 
detailed discussion, see Appendix I.
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Chapter II
THE IDENTIFICATION OF NOVEL COMPLEXES ASSOCIATED WITH 
TERMINATION FACTOR ERFl USING ANALYTICAL 
ULTRACENTRIFUGATION WITH A FLUORESCENCE DETECTION SYSTEM
Introduction
The use of AU-FDS to detect protein complexes with Flag-PABl identified a 77S 
monosomal complex (Wang et al., 2012). Previous studies using this method showed that 
these complexes contained translation termination factor eRF3 (Zhang, 2011). The 
presence of eRFl in complexes associated with Flag-PABl have also been observed (X. 
Wang & S. Park, pers. comm.). The intent of this project was to identify proteins that 
interact to form complexes with translation termination factor eRFl, the sedimentation 
values o f the complexes associated with eRFl, and the general trends o f glucose 
deprivation and cycloheximide treatment on these complexes. To identify the complexes 
associated with termination factor eRFl, AU-FDS analysis was performed on Flag-eRFl 
purified complexes. AU-FDS analysis revealed the presence of six distinct complexes, 
which have S values o f 20S, 28S, 39S, 57S, 77S, and complexes greater than 100S. The 
complexes greater than 100S are assumed to be polysomal material. AU-FDS analysis 
also revealed that the closed-loop components eIF4E, eIF4Gl, and PAB1 as well as 
ribosomal proteins RPS4B and RPL7A, and translation initiation factors eIF2a, eIF2y, 
and eIF3b interact with complexes containing eR F l.
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Materials and Methods
Growth conditions and Flag pulldowns
The yeast strains used for this study can be found in Table 1. The GFP fusion 
proteins in these strains have been shown to be functional and not cause any apparent 
growth defects (Huh et a l,  2003). Yeast cell cultures were grown as previously described 
(Wang et a l, 2012) to mid-log phase (optical density at 600 run o f 0.8 -  1.2). For glucose 
deprivation, a 1L culture was divided in half and the cells in one fraction were 
resuspended in glucose free media and incubated for ten minutes while the other half 
remained incubating in glucose-containing media prior to cell harvesting. A similar 
procedure was performed for cycloheximide treatment, where half o f a 1L culture was 
incubated with cycloheximide for ten minutes prior to harvesting cells. Flag-affinity 
pulldowns were performed as previously described (Wang et al., 2012). Generally, 425 
pL of eluent was collected, of which 300 pL were used for AU-FDS and 60 pL were 
diluted in 240 pL of lysis buffer lacking the yeast inhibitor cocktail (a 5-fold dilution) for 
AU absorbance analysis at 230 nm (AU-A23o)- Samples analyzed by AU ranged in 
concentration from 0.1 -  0.3 mg/mL and control samples lacking Flag-eRFl were in the 
0.01 -0 .0 3  mg/mL range.
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Name Genotype
RP1950-RPS4B/TK41 Mata ura3 leu2 his3 met 15 RPS4B-GFP-[HIS3J 
TK41 [URA3-Flaz-eRFl]
RPL7A/TK41 Isogenic to RP1950 except RPL7A-GFP-[H1S3]
RP1946/TK41 Isogenic to RP1950 except CDC33-GFP-[HIS3]
RP1947/TK41 Isogenic to RP1950 except TIF4631-GFP-[HIS3]
RP2191/TK41 Mata leu2-3,112 trpl ura3-52 his4-539
cupl::LEU2/PGKlpG/MFA2pG PABl-GFP(NEO)
RP2522/TK41 Isogenic to RP1950 except SUP35-GFP-[HIS3]
RP2529/TK41 Isogenic to RP1950 except HRP1-GFP-[HIS3]
GRPB1/TK41 Isogenic to RP1950 except RPB1-GFP-[HIS3]
GUPF1/TK41 Isogenic to RP1950 except UPF1-GFP-[HIS3]
GSGN1/TK41 Isogenic to RP1950 except SGN1-GFP-[HIS3J
GSSD1/TK41 Isogenic to RP1950 except SSD1-GFP-[HIS3J
YMK880/TK41 Mata ade2-l h is3-ll,15  leu2-3,112, trpl-1 ura3-l canl- 
100ADE2 GCD1-GFP.G418
YMK882/TK41 Isogenic to YMK880 except PRT1-GFP. G418
YMK883/TK41 Isogenic to YMK880 except SUI2-GFP:G418
YMK1171/TK41 Isogenic to YMK880 except T1F5-GFP.G418
YMK1211/TK41 Isogenic to YMK880 except GCDC11-GFP:G418
Table 1: Yeast strains used
Analytical ultracentrifugation parameters
Samples were subjected to AU analysis as previously described by Wang et 
al. (2012) with the following exceptions. The AU experiments were performed at 20°C at 
a rotor speed of 25,000 rpm. For the control and stress experiments, AU-FDS was 
performed for 150-200 scans. For the peak shift experiments, AU-FDS was performed for 
500-900 scans. AU-A230 was performed for at least 125 scans. Parameters for data 
analysis using the software Sedfit were set as described by Wang et al. (2012), except
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that the maximum S value was set to 150 and the resolution for the peak shift 
experiments was set to 200 data points.
Calculating absolute protein abundances in particular complexes
To assess the relative abundance of each target protein, AU-FDS and AU-A230 
were both run simultaneously with the Flag-affmity eluent. The x-coordinate values were 
first adjusted from experimental S values to the standard S2o,w- Using the program 
Sednterp, the conversion factor for the lysis buffer containing 10% glycerol was 
determined to be 1.51. All x-coordinates for AU-A230 and AU-FDS analysis were 
multiplied by this factor prior to performing peak size determinations or abundance 
calculations.
The S value for each peak was determined by identifying the local maximum y- 
value and recording the associated x-coordinate. The abundance o f each complex was 
determined by taking the integral of the peak seen in the AU analysis. The integral of a 
sedimentation peak is equal to its relative concentration since the function c(S) represents
tic—, the change in concentration over the change in sedimentation. Integration was
dS
simplified by taking a summation of the y-values for each peak and dividing it by the 
number of coordinates taken. The total number o f coordinates can be set in the Sedfit 
parameters and the software equally separates the x-values o f these coordinates. This 
allowed us to divide by the number of coordinates used rather than determining the total 
difference in x when making integral calculations. Comparison o f FDS peaks can be
24
compared to A230 peaks provided the resolution used in Sedfit for both sets o f data is the
#
same.
After the abundance of each FDS and A230 peak was determined, the FDS values 
were divided by the A230 values of the corresponding peak. This was performed to 
calculate the fluorescence abundance relative to the total amount o f protein and nucleic 
acid present at that peak. Absorbance at 230 nm detects protein/nucleic acid mixes with a 
3:1 ratio favoring protein. This relative abundance value was then compared to a standard 
protein to calculate its abundance relative to the standard (see Table 5). The standard 
protein varied by complex and can be identified as the protein set to 100% abundance in 
Table 5 (either eIF4E, RPS4B, or RPL7A). This provides a way to determine the 
proportions of components at each peak observed. For glucose deprivation experiments, 
the percentage of the glucose-deprived peaks relative to the peaks from the culture in 
regular media was calculated. Cycloheximide treatment calculations were performed 
similarly, wherein the percentage o f abundance of cycloheximide-treated peaks was 
compared to the normal growth condition. Glucose and cycloheximide treatment 




Identifying proteins in complexes containing eRFl
Yeast strains containing the Flag-eRFl plasmid versus strains lacking the plasmid 
were compared to identify proteins in Flag-eRFl complexes. AU analysis using A230 
absorbance optics was conducted, and typical results are shown in Figures 5A and B. 
Seven general complexes were detected: 15S, 20S, 28S, 39S, 57S, 77S, and complexes 
greater than 100S. Complexes greater than 100S are presumed to be polysomes (Wang et 
al., 2012), whereas the 77S complexes migrated with the monosomal translation complex 
or the free 80S ribosome. The smaller complexes of 57S and 39S had been visualized 
previously using Flag-PABl as bait but had remained uncharacterized (Wang et al.,
2012). Their sizes and components however, had indicated they at least contained the 60S 
and 40S ribosomal subunits, respectively. The complexes smaller than 39S had also been 
visualized in much lower concentrations using Flag-PABl pulldowns but were 
uncharacterized. Material smaller than 1 OS were generally considered to be monomeric 
proteins and were not further analyzed.
Strains containing green fluorescent protein (GFP) fused to the C-terminal end of 
various known proteins involved in protein synthesis were subsequently used to identify 
proteins that associate with each of these Flag-eRFl purified complexes. Single-step 
affinity purification of the Flag-eRFl protein was conducted with Flag-agarose beads and 
was followed by AU-FDS analysis. Each GFP fusion protein was assayed to determine its 
presence in Flag-eRFl complexes by comparison to the control AU-FDS analysis from 
extracts that lacked Flag-eRFl. The core protein components of the closed-loop structure
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(eIF4E, eIF4Gl, and PAB1) (see Figure 6, A-C) as well as RPS4B, RPL7A (Figure 6, D 
and E), eIF2a, eIF2y, eIF3b, and eRF3 (Figure 7, A-D) were found to associate with 
Flag-eRFl relative to the control. Proteins that did not exhibit much signal above the 
negative control signal included eIF2By, eIF5, HRP1, RPB1, SGN1, SSD1, and UPF1 
(Figures 8 & 9). In addition, these proteins also displayed very low signal intensity (c(S) 
below 0.05) as compared to the above proteins shown to be present in Flag-eRFl 
complexes, which generally had a c(S) signal intensity greater than 0.10. These proteins 
were not analyzed further.
The proteins identified to be in eRFl-specific complexes showed a number of 
novel complexes at 20S, 28S, 39S, and 57S as well as that o f the previously identified 
77S complex and polysomal material migrating at S values greater than 100S 
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Figure 5: A typical profile o f  AU-A 2 3 0  analysis o f  a Flag affinity pulldown o f  Flag-eRFl compared to the 
same strain lacking Flag-tagged eRFl. The two profiles show the profile range to a maximum o f  110 S (A) 
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Figure 6 : AU-FDS analysis o f  eRFl associated complexes using GFP fusions. Each profile compares the 
same GFP-fusion strain with and without Flag-eRFl after Flag purification. Flag control experiments were 
run at 25K rpm and analysis used 150-200 scans. The strains used for this figure were (A) RP1946/TK41 
(eIF4E-GFP), (B) RP1947/TK41 (eIF4Gl-GFP), (C) RP2191/TK41 (PAB 1-GFP), (D) RPS4B/TK41 
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Figure 7: AU-FDS analysis o f eRFl associated complexes using GFP fusions. Each profile compares the 
same GFP-fiision strain with and without Flag-eRFl after Flag purification. Flag control experiments were 
run at 25K rpm and analysis used 150-200 scans. The strains used for this figure were (A) YMK883/TK41 
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Figure 8 : Examples o f  GFP fusions that had low fluorescence signal and did not exhibit much more signal 
compared to the control following AU-FDS analysis. These fusions were not analyzed further. Each profile 
compares the same strain with and without Flag-eRFl after Flag purification. The strains used for this 
figure were (A) YMK880/TK41 (eIF2By-GFP), (B) YMK1171/TK41 (eIF5-GFP), (C) RP2529/TK41 
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Figure 9: Examples o f  GFP fusions that had low fluorescence signal and did not exhibit much more signal 
compared to the control following AU-FDS analysis. These fusions were not analyzed further. Each profile 
compares the same strain with and without Flag-eRFl after Flag purification. The strains used for this 
figure were (A) GSGN1/TK41 (SGN1-GFP), (B) GSSD1/TK41 (SSD1-GFP), (C) GUPF1/TK41 (UPF1- 
GFP)
Peak Name Average AU-FDS Average AU-A230
S Position S Position
15S 14.1 ±0.561 15.9 ±0.391
20S 20.1 ±0.422 22.0 ±0.443
28S 27.6 ±0.291 25.6 ±0.770
39S 38.8 ±0.347 35.8 ±0.294
57S 57.0 ±0.573 57.2 ±0.211
77S 74.4 ± 0.627 75.7 ±0.365
Table 2: Average peak S position o f each GFP-target sedimenting at that position. Error presented is 
standard error o f the mean (SEM). GFP-fusions used to determine the S positions were 15S: eIF4E-GFP, 
eIF4Gl-GFP, PAB1-GFP, eIF2a-GFP, and eIF2y-GFP. 20S: The same fusions as 15S and eIF3b-GFP. 
28S; The same fusions as 20S. 39S: The same fusions as 28S and RPS4B-GFP. 57S: The same fusions as 
39S and RPL7A-GFP, but not eIF3b-GFP. 77S: The same fusions as 57S, but including eIF3b-GFP. All 
mentioned GFP fusions were used to determine each A 2 3 0  peak.
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Effects of glucose depletion on Flag-eRF 1 containing complexes
It has been previously shown that translational complexes run off o f mRNA 
following the stress of glucose depletion (Ashe et al., 2000; Wang et al., 2012). For 
example, for Flag-PABl 77S monosomal translation complexes, glucose depletion results 
in a reduction to 25% of the abundance seen under normal glucose growth conditions 
(Wang et a l,  2012). Therefore, we used the effect o f glucose removal to determine which 
of the Flag-eRFl complexes were translationally active. As shown in Figure 10E, the 
AU-A230 profile indicates that only the polysomal material (greater than 100S) displayed 
a reduction in abundance following glucose depletion.
Similar analyses were conducted for individual GFP-tagged translation proteins 
(Figure 10 A-D, PAB1, eIF4Gl, RPS4B, and RPL7A, respectively). The effect of 
glucose deprivation on the abundance of each protein in each complex is summarized in 
Table 3. The polysomal material following glucose deprivation decreased to 25% for the 
ribosomal proteins and about 50% for eIF4Gl indicating these were eRFl-containing 
translationally active complexes. PAB1 did not show a large decrease in abundance at the 
polysomal position, but further repeats are necessary to confirm this.
In contrast to the polysomal material, the 77S complex did not show a significant 
change following glucose deprivation. This suggests that these complexes containing 
PAB1 and eIF4Gl are already translationally stalled and therefore cannot run-off the 
mRNA. However, the RPS4B and RPL7A containing complexes could be translationally 
stalled complexes or free 80S ribosome whose abundance is insensitive to glucose
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deprivation (Wang et al,, 2012). In addition, the A230 profile o f the peaks observed below 
77S showed little change or possibly increased in abundance in response to glucose 
deprivation, as previously seen (Wang et al., 2012). An increase in abundance following 
glucose deprivation would be consistent with the complexes forming post-runoff and 
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Figure 10: AU-FDS analysis was performed at 25,000 rpm for 150-200 scans. Samples run were prepared 
from the same culture before and after 1 0  minute glucose depletion and each pair was run on the same day. 
Strains used for this figure were (A) RP2191/TK41 (PAB1-GFP), (B) RP1947/TK41 (eIF4Gl-GFP), (C) 
RPS4B/TK41 (RPS4B-GFP), (D) RPL7A/TK41 (RPL7A-GFP), (E) RPL7A/TK41 (RPL7A-GFP)
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Target 20S 28S 39S 57S 77S 100-200S
eIF4Gl 131 ± 14 145 ±6.2 110 ± 16 163 ± 7 .9 74 ± 15 45 ± 11
PAB1 96 74 151 94 63 72
RPS4B N/A N/A 137 ±1.1 49 ± 3 7 113 ± 12 28 ± 18
RPL7A N/A N/A N/A 140 178 13
A230 169 ±7.8 92 ± 39 102 ±9.1 135 ± 17 123 ± 14 78 ± 24
Table 3: Change in abundance (AU-FDS or A230) o f  GFP fusion target after 10 minute glucose deprivation. 
Values are presented as percent o f  the abundance before glucose depletion.
Effects of cycloheximide treatment on Flag-eRFl containing complexes
It has been previously shown that cycloheximide prevents the translational 
complex from leaving the mRNA (Wang et al., 2012). This is because cycloheximide 
inhibits the translocation step of the ribosome during elongation. Cycloheximide 
treatment was performed to determine if  the complexes smaller than 77S were pre­
initiation complexes. While cycloheximide inhibits translation, transcription is not 
inhibited. If the smaller complexes were pre-initiation complexes, we might expect that 
their abundances would increase after cycloheximide treatment. However, there was no 
large increase in abundance seen in complexes smaller than 77S. Most abundances were 
similar or decreased after treatment (Table 4). This result is consistent with the model 
that the majority of the eRFl-containing complexes are termination complexes that fail to 
form if elongation is blocked.
Polysomal material associated with Flag-PABl was previously shown to be 
stabilized by cycloheximide, causing an increase by about 2-fold o f the polysomal 
material. This indicates that these polysomal complexes were translationally active
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elongating complexes (Wang et al., 2012). However, the majority o f polysomal material 
associated with Flag-eRFl remained at a relatively similar abundance if not actually 
decreasing in abundance following cycloheximide treatment. Again, this is consistent 
with the model that these polysomal complexes containing eRFl are termination 
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Figure 11: AU-FDS analysis was performed at 25,000 rpm for 150-200 scans. The samples run were 
prepared from the same culture before and after 10 minute cycloheximide treatment and each pair was run 
on the same day. Strains used for this figure were (A) RP1946/TK41 (eIF4E-GFP), (B) RP2191/TK41 
(PAB 1-GFP), (C) RP1946/TK41 (eIF4E-GFP), (D) RP1947/TK41 (eIF4G 1-GFP), (E) RPS4B/TK41 
(RPS4B-GFP)
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Target 20S 28S 39S 57S 77S 100-200S
eIF4E 113 ± 5.9 N/A* 97 ±31 113 ± 7 .6 101 ± 3 .4 60 ±2.7
eIF4Gl 127 124 123 122 141 104
PAB1 114 80 87 103 34 21
RPS4B N/A N/A 109 ± 16 89 ± 4 7 96 ± 22 80 ±4.0
A230 97 ±6.1 131 ± 6 .9 103 ±7.5 106 ± 9 .9 87 ± 11 77 ± 15
T able 4: Change in abundance (FDS or A 2 3 0) o f  GFP fusion target after 10 minute incubation with 
cycloheximide. Values are presented as percent o f  the abundance before cycloheximide treatment. The 
eIF4E cycloheximide experiments were performed before the complex shift phenomenon was observed. 
The number o f  scans used for the eIF4E analysis did not allow for the clear determination o f  the 28S peak 
abundance.
Determining the stoichiometry of translation components in each complex
In order to absolutely determine the particular abundance o f a protein in a 
particular complex, the ratio of the abundance of a protein was determined by AU-FDS 
and compared to the total protein in that particular peak using AU-A230 analysis (see 
Materials and Methods section). The values provided in Table 5 were calculated from 
experiments where AU-A23owas run simultaneously with AU-FDS.
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Protein 20S 28S 39S 57S 77S
eIF4E 100% 100% 22 ± 2.8 13 ±0.82 13 ±0.81
eIF4Gl 46 ± 1.6 46 ± 2.4 15 ± 2 .9 8.4 ± 1.9 7.1 ± 1.2
PAB1 40 ± 9.9 49 ± 1.7 19 ± 3.3 9.0 ± 0.40 10 ± 3.3
eIF2y 212 ±78 106 ± 37 22 ± 4.9 11 ± 1.2 8.0 ± 1.3
eIF2a 34 ± 1.8 35 ± 1.8 5.0 ±0.61 2.6 ± 1.3 0.85 ±0.34
eIF3b 45 ±0.55 29 ± 9.5 ,16 ±0.21 N/A N/A
RPS4B N/A N/A 100% 13 ± 3.1 100%
RPL7A N/A N/A N/A 100% 117 ± 18
eRF3 6500 ± 340 2700 ± 500 N/A 9 5 0 ± 150 800 ± 280
Table 5: Relative abundance o f  each protein at the identified peak positions. The abundances at 20S and 
28S were compared to the abundance o f  eIF4E, The abundances at 39S and 77S were compared to the 
abundance o f  RPS4B. The abundances at 57S were compared to the abundance o f  RPL7A. Values 
presented are percentage o f  abundance o f  the target protein compared to the different standard proteins. 
Error presented is SEM.
The 77S complex associated with Flag-eRFl mostly contained the large and small 
ribosomal subunit proteins RPL7A and RPS4B, respectively (approximately 85% 
assuming separate pools o f free ribosome and ribosomes with translationally stalled 
monosomal complexes that contained eIF4E, eIF4Gl, and PAB1, see below). This 
complex did not have a major response to stressors as previously characterized, 
indicating that the majority of complexes at the 77S position behave like free 80S 
ribosome (Wang et al., 2012). The rest o f the complexes which contain the closed-loop 
proteins (13% based on eIF4E abundance) must also have an 80S ribosome and mRNA 
associated with them. We assume mRNA is present in these complexes because eIF4E 
binds the mRNA cap and PAB1 binds the poly(A) tail. However, these complexes may 
not all be translationally active because glucose depletion did not reduce the abundance
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of these components to the degree observed for translationally active complexes 
containing Flag-PABl (Wang et a l , 2012).
The 57S complex associated with Flag-eRFl is mostly comprised of the large 
ribosomal subunit protein RPL7A. Based on different pools of complexes as described 
for the 77S complex, these ribosomal subunit complexes comprise approximately 85% of 
these complexes. Translation termination factor eRFl has been shown to interact with the 
60S subunit of the ribosome and may be associating with free 60S subunits (Taylor et a l, 
2012). It appears that the remainder o f these complexes (13% based on eIF4E abundance) 
have similar abundances of the closed-loop proteins in addition to the small ribosomal 
subunit protein RPS4B. These complexes may be post-termination complexes which 
contain the small subunit still bound to the mRNA. It has been shown that eRFl will 
remain associated with the small subunit on the ribosome following ribosome subunit 
separation by eIF3 (Pisarev et al., 2010). Another possibility is that there is a pool of 
complexes which contain the closed-loop proteins as well as full ribosome, but have 
undergone a conformational change causing a shift in peak position. It is unlikely that 
this peak consists of mRNP complexes that have undergone ribosome separation during 
the affinity purification. Previous studies have found that active dissociation of 
translational complexes does not occur during the affinity purification process (Wang et 
a l, 2012).
The 39S Flag-eRFl associated complex consists primarily o f the small ribosomal 
subunit protein RPS4B. It is possible this pool of complexes mostly contains free 40S
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subunit associated with eRFl, since eRFl has known sites o f interaction with the 40S 
subunit (Taylor et al., 2010). The remainder of this pool of complexes may simply be the 
closed-loop proteins associated with mRNA, which still have a 40S subunit bound to 
them.
All of the Flag-eRFl associating complexes migrating at 28S contain eIF4E and 
approximately half contain PAB1. These factors require mRNA to be present for this type 
of association. This pool likely contains various complexes with mRNA and different 
proportions of the various closed-loop proteins, each complex with eIF4E still associated. 
It is likely that the 28S complex is related to the 20S complex since they have similar 
abundances of each target protein. The shifting position of the 20S complex during 
sedimentation may be either due to an unwinding effect of this complex, resulting in a 
conformational shape change of the complex or a change in composition (see below). For 
more detailed interpretations of the complexes associated with Flag-eRFl, see the 
discussion section.
Shifting S value for the 20S complex
An additional observation that was made was that increasing the number of scans 
taken with the AU-FDS analysis resulted in a shift in the S value of peaks in the 10S-20S 
range for eIF4E, eIF4Gl, PAB1, eIF2a, and eIF2y without a change in total abundance 
(Figures 12A and C, 13A, 14A and C). The shift in this region in contrast to the fixed 
position of the IS peak and peaks larger than 20S are indicative o f a reaction boundary 
rather than a sedimentation boundary. In other words, this shift is consistent with a 
change in composition of the complex or a pressure effect on the complex during
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sedimentation. The shift appears when comparing scans ranging from 200 to 500. The 
shift ceases after 500 scans (Figures 12B and D, 14B and D) indicating that the change in 
forms have reached equilibrium at later times. As sedimentation occurs, the pools of 
complexes at 20S becomes more distinct. In contrast, the initiation factor eIF3b does not 
show this shifting behavior for its peaks (Figure 14E). However, initiation factor eIF2y 
behaved similarly to the closed-loop components. Its 18S complex (Figure 14C) at a low 
number of scans migrated and settled into peaks at 17S and 12S after a high number of 
scans (Figure 14D). This shifting behavior could be due to either a change in composition 
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Figure 12: GFP fusion targets that sediment below 28S shift sedimentation position between 200 and 500 
scans. Targets that sediment above 30S do not show this shifting pattern. Samples were run at 25,000 rpm. 
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Figure 13: GFP fusion targets that sediment below 28S shift sedimentation position between 200 and 500 
scans. Targets that sediment above 30S do not show this shifting pattern. Samples were run at 25,000 rpm. 
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Figure 14: GFP fusion targets that sediment below 28S shift sedimentation position between 200 and 500 
scans. Targets that sediment above 30S do not show this shifting pattern. Initiation factor eIF3b does not 
exhibit the shift below 28S. Samples were run at 25,000 rpm. Strains used for this figure were (A, B) 
YMK883/TK41 (eIF2cc-GFP), (C, D) YMK1211/TK41 (eIF2y-GFP), (E) YMK882/TK41 (eIF3b-GFP).
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The abundance of termination factor eRF3 suggests a possible prion effect
Termination factors eRFl and eRF3 have been shown to interact with each other 
using various biochemical methods (Stansfield et al., 1995; Krogan et al., 2006; Collins 
et al., 2007). Using AU-FDS, eRF3-GFP was identified as present in Flag-eRFl 
pulldowns (Figure 7D). However, the abundance of eRF3 present in eRFl associated 
complexes was found to be much greater than any other eRFl-interacting protein (Figure 
7D). Major peaks for eRF3 appear at 19S and 23 S followed by a high abundance signal 
with less distinct peaks into the 100S region. The abundance throughout the eRF3 profile 
is also unaffected by glucose deprivation or cycloheximide treatment (Figure 15A). The 
estimated eRF3 abundance in 77S, 57S, 28S, and 20S regions is many fold higher than 
the observed abundances o f the ribosomal proteins associated with eRFl complexes (see 
Figures 6D and E, and 1C). These observations suggest that there are multiple copies 
eRF3 molecules in each complex. The abundances of eRF3-GFP in the more clearly 
defined peaks (Figure 7D) were found to be 8 to 60-fold greater than the ribosomal 
proteins or eIF4E (Table 5). Since it has been found that eRF3 can act like a prion factor 
in yeast, creating a barrel shaped polymer, eRF3 self-aggregation could explain the 
increased abundances that are observed (Namy et al., 2008).
AU-FDS experiments with a dilution series o f eRF3-GFP were subsequently 
conducted to determine if the putative aggregated eRF3 was acting as if  it formed a 
micelle structure. If there is an equilibrium between a monomer and a micelle structure, 
then decreasing the concentration of the complex prior to AU-FDS analysis would favor 
disassociation and movement of the peaks to a smaller S value. Using a series of dilutions
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of eRF3-GFP sample following a Flag-eRFl pulldown, no difference was found in the 
movement or abundance of the 18S and 28S peaks (Figure 15B). These results do not 
support a micelle model for eRF3 in these complexes.
AU-FDS eRF3-GFP 
Flag-eRFl Pulldown Dilution Series
90.00AU-FDS eRF3-GFP 
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Figure 15: AU-FDS was performed at 25K rpm. (A) The same culture was used to perform ten minute 
glucose deprivation and ten minute cycloheximide treatment. (B) The same elution sample was used to 
create each dilution in the series. The strain used for this figure was RP2522/TK41 (eRF3-GFP).
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Discussion
In this thesis I used AU-FDS to in seek the identity and characteristics of protein 
complexes involved in protein translation. By immunoprecipitating translation 
termination factor Flag-eRFl in conjunction with various protein targets previously 
identified with mRNP complexes my studies revealed several complexes that migrate at 
sedimentation values previously unseen or uncharacterized. Overall, these eRFl 
complexes may represent termination complexes. There are several pieces o f evidence to 
support this. First, the complexes contain both eRFl and eRF3, key elements for 
translation termination. Secondly, general insensitivity of the 77S complex containing 
closed-loop component eIF4Gl to glucose deprivation treatment suggests that this 
complex is probably not translationally active. Third, cycloheximide treatment, blocking 
the translocation elongation step, did not increase the abundance of these complexes, 
which is consistent with their formation after elongation. Fourth, complexes smaller than 
28 S do not increase after cycloheximide treatment, suggesting they are not newly 
transcribed pre-initiation complexes.
The 77S complex
The 77S complex identified with Flag-eRFl contains components similar to the 
monosomal translating complex previously identified by our lab (Wang et a l,  2012). 
These components are the small and large ribosomal subunit proteins RPS4B and 
RPL7A, respectively, and the closed-loop components eIF4E, eIF4Gl, and PAB1. 
However, this 77S complex has different characteristics compared to the monosomal 
translating complex. First, it does not respond in the same manner as the previously
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identified complex to stress conditions. Glucose depletion causes runoff in translation of 
a majority of translationally active mRNP complexes. The relative insensitivity of the 
Flag-eRFl 77S complex to glucose deprivation indicates that the complex associated 
with eRFl might already be translationally stalled or that the majority o f the Flag-eRFl 
77S complexes are actually free 80S ribosome, which are known to be insensitive to the 
effects o f glucose deprivation.
The relative abundance of the mRNP closed-loop complex components relative to 
the ribosomal proteins RPS4B and RPL7A indicate that the majority o f complexes 
migrating at 77S are actually free 80S ribosomes (approximately 85%). This is indicated 
by the relatively low abundance of eIF4E, eIF4Gl, and PAB1 relative to the ribosomal 
proteins. The smaller pool of 77S mRNP complexes contains similar amounts of the core 
components eIF4E, eIF4Gl, and PAB1. Interestingly, eIF2y is also present in a similar 
abundance in this complex as the closed-loop complex components. The presence of eIF2 
may be part of the role eRFl plays in its suggested involvement in ribosome recycling 
(Shoemaker & Green, 2011).
The abundance of the 77S complex containing the closed-loop components was 
relatively insensitive to glucose deprivation, which is unlike the reduction of the 77S 
monosomal complex by glucose deprivation previously observed (Wang et al., 2012). 
Therefore, it is unlikely that the eRFl containing complexes at 77S with closed-loop 
components consists o f both monosomal complexes as well as stalled complexes, but 
rather a combination of free 80S ribosome and stalled complexes. Crystal structures o f
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mammalian free 80S ribosome combined with eRFl-eRF3-GMPPNP in vitro revealed 
that eRFl interacts with the intersubunit space o f the 80S ribosome (Taylor et al., 2012). 
The affinity of the eRFl/eRF3 complex for the 80S ribosome could explain the presence 
of the free ribosomes in the 77S complex pool.
The 57S Complex
The 57S complex associated with eRFl is mostly comprised of the large subunit 
of the ribosome as indicated by the abundance of RPL7A relative to closed-loop 
components. This may be a product of the splitting of the free 80S ribosome seen in the 
77S complex. The initiation factor eIF3b can dissociate the 80S ribosome by itself and 
was observed to associate with eRFl complexes (Figure 14E) (Pisarev et al, 2010). 
However, this dissociation most likely occurred prior to lysing the cells since degradation 
of translation complexes has not been observed during the affinity purification process 
(Wang et a l,  2012). If this were true, then the large portion of 60S ribosome subunit 
comprising the 57S peak must be directly interacting with eR F l. Crystal structures of 
mammalian free 80S ribosome with eRFl-eRF3-GMPPNP have revealed that eRFl 
interacts with the 60S subunit in vitro (Taylor et a l ,  2012). This interaction could explain 
the presence of the high abundance of RPL7A in the 57S complex.
The remaining pool of 57S complexes contained closed loop components 
consisting of similar levels of the components that are found in the 77S peak. 
Interestingly, this smaller pool of mRNP complexes also contains a similar abundance of 
RPS4B as the core mRNP components. Two models could explain the presence of
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RPS4B, The first is that RPS4B and RPL7A are present together, although that would 
lead one to an expected much larger S value. The smaller S value o f 57S may be 
explained by a “dumbbell” effect, wherein the 60S subunit o f the ribosome is in the 
process of terminating at the 5’ end while a 40S subunit is beginning a new round of 
translation at the 3’ end. Having such large components at either end o f the mRNA would 
create a very elongated shape. Sedimenting targets that are 2-3 times longer than their 
width have an S value shift of approximately 1.4-fold that of the expected mass assuming 
a spherical shape. This elongation factor agrees well with the S value seen at 57S versus 
77S. Again, the presence of eIF2 may suggest a new round o f translation is beginning in 
this smaller pool of complexes.
The second model is that RPS4B is only associated with mRNA containing the 
closed-loop components, since they are present in similar abundance. In this case, this 
40S-mRNA-closed-loop component 57S complex would be most similar to the predicted 
splitting apart of the translating ribosome following termination.
The 39S Complex
The 39S complex associated with eRFl contains the small subunit o f the 
ribosome but no large ribosomal subunit. Once again, there is a smaller pool of 
complexes that contain similar amounts of the closed-loop mRNP components. In 
addition, the initiation factor eIF3b also appears here with a similar abundance as 
compared to the closed-loop components. A possible model for the presence of both eIF2 
and eIF3b would be that this smaller pool of complexes is actually in the process of
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initiation following termination. This complex might be similar to the 48 S initiation 
complex. After peptide release, eRFl remains bound to the ribosome until it is split by 
eIF3 (Pisarev et al., 2010). Also, eRFl has been proposed to remain attached to the 40S 
ribosome post-termination until the mRNA is released by elF l and eIF3j (Pisarev et a l,  
2007b) and some eRFl and eRF3 is known to be present on translation initiation 
complexes (Amrani et al, 2008). Perhaps the association between eIF3b and eRFl is 
indicative of eR F l’s ability to assist in recycling o f the ribosome for additional rounds of 
translation following termination prior to degradation. The abundance of the 39S 
complex was insensitive to cycloheximide treatment. Since transcription continues during 
cycloheximide treatment, one would expect new mRNA to form more pre-initiation 
complexes. However, if the eRFl-associated 39S complex forms after translation 
termination and is not the result o f new mRNA forming the 48S complex, then blocking 
elongation with cycloheximide would not cause an increase in the 39S complex, which is 
what was observed.
The 28S Complex
Assuming a spherical shape, the predicted size of a 28S complex is 832 kDa. The 
sum of the mass o f the average yeast mRNA (600kDa) plus eIF4E, eIF4Gl, PAB1, eRFl, 
and GFP gives a total of 871 kDa. We assume all o f the complexes in the 28S peak 
contain the cap binding protein eIF4E. The assumption is based on the stoichiometric 
estimations seen in Table 5. However, not all of the complexes in this region appear to 
contain the other closed-loop complex proteins typically associated with mRNP 
formation. PAB1 and eIF4Gl have roughly half o f the abundance as compared to eIF4E.
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The relative abundance of these components suggest that there are likely multiple pools 
of complexes at 28S comprised of various closed-loop elements with each containing 
eIF4E. The above calculated mass o f 871 kDa would be 807 kDa if  lacking PAB1 and 
764 kDa if  lacking eIF4Gl, which would have approximate S values o f 27.4S and 26.4S, 
respectively.
The size of this complex and the presence of eIF4E strongly suggests that there is 
mRNA present in these complexes. Perhaps the portion of complexes that do not contain 
eIF4Gl or PAB1 are termination products awaiting degradation. The complexes that 
would contain all of the closed-loop components (if all of the components are found 
together and not in separate pools) also have similar abundances o f the initiation factors 
eIF2 and eIF3. This suggests that these may be complexes preparing for a new round of 
translation.
The 20S Complex
The components of the 20S complex are present at levels similar to that o f the 
28S complex. Given this fact, we would expect them to have a similar MW. However, 
the approximate mass of a spherical 20S complex would be 502 kDa. The discrepancy 
could be explained by an elongated form of the 28S complex. A 2-3 ratio o f length to 
width elongated form of a 28S sized complex would run at approximately 20S (a 1.4-fold 
difference).
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The 20S peak is one of the peaks that shift during the sedimentation experiment 
and its initial position is closer to the 28S peak and shifts to a lower position before 
settling at 20S. This indicates that it is either losing components or undergoing a shape 
change. If this is the 28S complex losing components, then the components lost are not 
one of the core components, since their abundance does not change relative to the 28S. 
The lost components would, therefore, be proteins not targeted during these experiments. 
Proteins that may be worth targeting to investigate the possibility o f composition change 
include R lil, Dbp5, and Ittl. Each of these proteins has been indicated to interact with 
eRFl and have importance in the regulation of translation termination (Shoemaker & 
Green, 2011; Gross et al., 2007; Urakov et al., 2001). Alternatively, the 20S complex 
may change shape during the AU-FDS experiment. This could occur if the 20S complex 
begins to unravel with time and assume a more elongated shape and therefore have a 
lower S value. However, this shape change would have likely reached equilibrium prior 
to centrifugation. This change may also be caused by a pressure effect during 
centrifugation. This would be caused by a change in pressure in the centrifuge cell as 
complexes are sedimenting.
Complexes smaller than 20S
In addition to the five peaks mentioned above, some of the targets were seen at 
smaller S values. Each GFP component analyzed displayed a peak at an S value similar to 
the one estimated for the MW of its monomer plus the MW of the GFP they were fused 
with, ranging from 4.4 - 9.0S. These values are well below the expected value of the 
GFP-fused monomer plus eRFl, indicating that the monomer has dissociated from an
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eRFl associated complex at some point during the affinity pulldown. PAB1 was present 
in a complex at 10S that increased in abundance as sedimentation occurred. The 10S peak 
correlates well with the MW of a dimer o f PAB1-GFP (which is 150 kDa), suggesting 
that PAB1 is self-associating during the sedimentation experiment and subsequently 
splitting into a monomer form.
Closed-loop components
The relative abundance of the closed-loop components in the complexes larger 
than 28S suggest that only a small portion of the complexes associated with eRFl contain 
closed-loop mRNPs with ribosomes attached. It appears that eRFl is associating with or 
remains associated with ribosomal subunits post-termination. The shift in abundance of 
the various closed-loop structure proteins during stress also indicates that the pool of 
mRNP complexes that are associated with ribosomal subunits are in the process of 
termination. The relative abundances o f the closed-loop components in the 28S and 20S 
complexes suggests that the majority of these complexes are in various states of 
decomposition. However, the presence of eIF2 and eIF3 in these smaller complexes 
suggest that some of these complexes may be involved in re-initiation. The 
cylcloheximide effects on these small complexes suggest that the eIF2 and eIF3 
associations are not a result of new mRNA being prepared for translation initiation.
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GENERAL DISCUSSION
In Chapter 1, analysis of the interaction between UPF1 and PAB1 revealed that 
the RRM1 deletion prevented deadenylation but not decapping in UPF1-mediated NMD. 
Additionally, deleting UPF1 prevented a shift from distributive to processive 
deadenylation. This result suggests that UPF1 is the long sought after factor that controls 
normal acceleration of deadenylation, a process critical to all mRNA degradation. The 
presence of the RRM1 domain of PAB1 was required for UPF1 effects, but whether this 
is critical for this newly identified function of UPF1 remains to be clarified.
In Chapter 2, AU-FDS analysis revealed the presence of six distinct complexes 
that associate with Flag-eRFl. These complexes have S values o f 20S, 28S, 39S, 57S, 
77S, as well as complexes >100S. Analysis of the various components associating with 
Flag-eRFl revealed that the closed-loop components of mRNP complexes (eIF4E, 
eIF4Gl, and PAB1) are present in all o f the complexes identified. Furthermore, small 
ribosomal protein RPS4B was identified in the 39S, 57S, 77S, and >100S complexes. 
Large ribosomal subunit protein RPL7A was identified in the 57S, 77S, and >100S 
complexes as well.
Stoichiometric analysis revealed that the 39S, 57S, and 77S complexes are mostly 
comprised of free ribosomal material, the remainder of the pool consisting of ribosomal 
associated closed-loop components. The smaller complexes at 28S and 20S all contained 
eIF4E with various mixtures of the other closed-loop components. These complexes also
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contained a relatively similar abundance of eIF2y and eIF3b in comparison to the closed- 
loop components. The 20S complex revealed a peak shift behavior that is possibly the 
effect of either a loss of certain components during sedimentation a change in shape of 
the complex.
The stress effects o f glucose and cycloheximide revealed that these complexes are 
probably not translationally active. For the 77S complex, this is consistent with it being 
primarily comprised of the free 80S ribosome whose abundance is also unaffected by 
glucose deprivation (Wang et al., 2012). Cycloheximide treatment did not cause an 
increase in abundance of the ribosome-free smaller complexes, suggesting that these 
complexes are not pre-initiation complexes transcribed after the addition o f the 
cycloheximide but are rather post-termination complexes.
Further analyses of complexes associated with eRFl need to be performed to 
further elucidate the roles o f these complexes. Additional repeats o f glucose deprivation 
must be performed to clarify the relative abundances of PAB1 and eIF4E in these 
complexes. In order to clarify if any of these complexes are initiation complexes forming 
after termination, experiments in which glucose is depleted and then restored for a short 
time should be performed. Such experiments will determine if  there is an effect on the 
abundance of the initiation factors eIF3 and eIF2 in order to clarify the possibility that the 
smaller complexes are involved in re-initiation of terminating complexes. Finally, 
termination events can be looked at more directly by conducting 1 min heat shock 
experiments in which translational run-off and termination predominantly occur.
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To further explore the results obtained with Flag-eRFl complexes, the complexes 
and components obtained with Flag-eRF3 pull-down could be done. It would be expected 
that Flag-eRF3 complexes would be similar to those obtained with Flag-eRFl. Also, 
experiments adjusting the levels o f Mg2+ in solution may provide interesting results as the 
concentration of Mg2+ has been shown to effect eRFl-eRF3 interactions as well as eRFl 
interactions with post-termination complexes in vitro (Pisarev et al., 2010).
These above types of experiments would help in clarifying whether the eRFl 
complexes that I have detected are primarily termination complexes. Dissecting whether 
multiple types of complexes exist at each peak size (for example, 57S) may be more 
difficult to accomplish. Experiments in which other baits are used to detect 57S 
complexes, such as eIF4E-Flag, eRF3-Flag, or eIF4Gl-Flag, may aid this process. 
Clearly, the large number of distinct complexes observed with eRFl suggest that 
translation termination holds many secrets yet to be revealed.
Finally, my data suggests that eRF3 is forming multimers in a prion-like 
configuration and warrants further investigation. One way to approach this would be to 
determine if other known eRF3 prion-associated factors, such as SSA2, SSE1, and YDJ1, 
are present in the eRFl complexes that I have detected. If these proteins were to be 
present, then that would strengthen the argument that at least under termination 
conditions eRF3 is forming multiple prion-like particles. Whether these particles have 
any specific role in termination remains to be determined. Since actively translating 77S
58
complexes purified with Flag-PABl have only very low levels o f eRF3 (about 1% of the 
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Abstract Poly (A) binding protein (PAB1) is involved in 
a number of RNA metabolic functions in eukaryotic cells 
and correspondingly is suggested to associate with a 
number of proteins. We have used mass spectrometric 
analysis to identify 55 non-ribosomal proteins that specif­
ically interact with PAB1 from Saccharomyces cerevisiae. 
Because many of these factors may associate only 
indirectly with PAB1 by being components of the PAB1- 
mRNP structure, we additionally conducted mass spectro­
metric analyses on seven metabolically defined PAB1 
deletion derivatives to delimit the interactions between 
these proteins and PAB1. These latter analyses identified 
13 proteins whose associations with PAB1 were reduced by 
deleting one or another of PA B l’s defined domains. 
Included in this list of 13 proteins were the translation 
initiation factors eIF4Gl and eIF4G2, translation termina­
tion factor eRF3, and PBP2, all of whose previously known 
direct interactions with specific PAB1 domains were either 
confirmed, delimited, or extended. The remaining nine 
proteins that interacted through a specific PAB1 domain 
were CBF5, SLF1, UPF1, CBC1, SSD1, NOP77,
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yGR250c, NAB 6 , and GBP2. In further study, UPF1, 
involved in nonsense-mediated decay, was confirmed to 
interact with PAB1 through the RRM1 domain. We addi­
tionally established that while the RRM1 domain of PAB1 
was required for UPF1-induced acceleration of deadeny­
lation during nonsense-mediated decay, it was not required 
for the more critical step of acceleration of mRNA 
decapping. These results begin to identify the proteins most 
likely to interact with PAB1 and the domains of PAB1 
through which these contacts are made.
Keywords PAB1 • Proteome • UPF1 ■ Nonsense- 
mediated decay • Protein domain interactions
Introduction
The poly(A) binding protein (PAB1 from Saccharomyces 
cerevisiae and PABPC from humans) binds the poly(A) tail 
of mRNA and functions at a number of steps involving 
RNA metabolism (Kuhn and Wahle 2004; Mangus et al.
2003). mRNA polyadenylation, export, translation, and 
turnover have all been shown to be affected by PAB1 
(Kuhn and Wahle 2004; Mangus et al. 2003; Hosoda et al.
2006). The fact that PAB1 plays a number of roles in both 
the nucleus and the cytoplasm indicates that it may be in 
contact with multiple proteins and complexes and that 
these interactions may dictate its functions. Most impor­
tantly, PAB1 protein interactions may be continually 
changing as it regulates RNA metabolism in the cell.
Several whole organism proteomic analyses have been 
conducted to identify all the protein complexes within a 
yeast cell or involved in a given process (Gavin et al. 2002; 
Ho et al. 2002; Krogan et al. 2004; Staub et al. 2006). A 
summary of mass spectrometric analyses involving purified
67 4?) Springer
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TAP-tagged proteins has identified 41 significant non- 
ribosomal protein interactions with PAB1 (Coilins et al.
2007), and other studies have demonstrated additional 
putative PAB1 protein targets (SGD database). Yet, for the 
most part, the significance of these interactions has not 
been defined, nor has the domains of PAB1 important for 
these contacts been determined.
The PAB1 protein consists o f six readily defined func­
tional regions (Fig. 1). At its N-terminus are four RNA 
binding motifs (RRM domains). While RRM1 and RRM2 
of PAB1 appear to bind most strongly to poly(A) (Kessler 
and Sachs 1998; Deardorff and Sachs 1997), RRM3 and 
RRM4 can also make critical contacts (Kessler and Sachs 
1998; Deardorff and Sachs 1997; Deo et al. 1999) and may 
bind U-rich regions located adjacent to the poly(A) tail 
(Mullin et al. 2004; Sladic et al. 2004). Its C-terminal 
region comprises a penultimate proline-rich (P) domain 
and a terminal structured region (C), neither of which is 
critical for RNA binding (Kessler and Sachs 1998; Yao 
et al. 2007). Each RRM domain is comprised of four 
antiparallel ft-strands (the RNA binding surface) that is 
backed by two a-helices (Deo et al. 1999).
A few of the protein contacts for each of these PAB1 
domains have been defined through conventional biochemi­
cal analyses. For example, the C region of PAB1 binds the 
PAN2/3 deadenylase (Siddiqui et al. 2007; Mangus et al. 
1998,2004) that functions in poly(A) trimming. Whether this 
process takes place solely in the nucleus, upon export, or in 
the cytoplasm is still not clear (Brown et al. 1996; Brown and 
Sachs 1998; Kuhn and Wahle 2004). The translation
termination factor eRF3 also contacts the C-terminus (Ho- 
soda et al. 2003), as do other proteins in mammalian systems 
(Kuhn and Wahle 2004; Mangus et al. 1998, 2004). The P 
domain is responsible for PAB1 self-association (Yao et al. 
2007; Melo et al. 2003; Kuhn and Pieler 1996). RRM2, with 
the aid of RRM1, contacts eIF4G (Tarun and Sachs 1996), 
important in forming the closed-loop structure of mRNA 
(Kuhn and Wahle 2004). Some of the key residues for this 
interaction in RRM2 are 180-182 and 184—187, whose 
alterations in vitro block PABl-eEF4G contacts and transla­
tion (Otero et al. 1999). The RRM1 and the P domain are most 
important to PAB1 for deadenylation by the major deaden­
ylase CCR4-NOT (Yao et al. 2007; Lee et al. 2010). The 
RRM1 domain but not the P domain was also found to be most 
critical for PUF3-induced deadenylation (Lee et al. 2010). 
Both of these regions of PAB1 were also shown to be critical 
for PAB1 self-association (Yao et al. 2007). In contrast, 
deleting the RRM3 domain accelerated deadenylation by 
some unknown mechanism (Yao et al. 2007). Also, deletion 
of RRM4, but not other domains, has been shown to reduce 
mRNA transport to the cytoplasm (K. Weis, personal com­
munication) (Brune et al. 2005; Simon and Seraphin 2007). 
Finally, in vivo protein synthesis analysis indicates that 
RRM1 and RRM2 are more critical to this process (Yao et al. 
2007; Ohn et al. 2007) with the other domains having no or 
limited effect on in vivo translation (see Table 1 for a sum­
mary of known PAB1 domain contacts).
To expand on previous studies that used mass spectro­
metric techniques to detect proteins interacting with 
PAB1, we have included two control mass spectrometric
PAB1-1,2,3,4,P,C(WT) j  RRM1 )-j  R RM2)—[ RHM3 j— [ RRM4 ]---------- E [ C j-
PAB1-ARRM1 ( RRM2 j—( RRH3 |— [ RRM4 ]-----------  [ C
PAB1-ARRM2 -j  RRM1 j- -( RRM3 |— { RHM4 j----------   [ C )-
PAB1-ARRM3 j  RRM1 |- |~RRM21- —| RRM4 )------------£  [ C }-
PAB1-ARRM4 j  RRM1 |-j  RRM2 [- ( RRM3 }-     ( C }-
PAB1-AP j  RRM1}-[ RRM21- | RRM3 )—[ RRM4)- -( c ) -
PAB1-AC -[ RRM1 )- [ RRMZ |- | RRM3 ) [ RRM4 [--------------------
  *T«
PAB1-134 -|  RRM1)—( RRM2 ]—j RRM3 ]— [ RRM4 |------------   ( C )-
»r«
PAB1-104 -| RRM1 )- | RRM2)- [ RRU3 |— | RRM4 [------------  1 C [-
PAB1-F170V j  RRM1)- ( RRM2 j—( RRM31— [ r RM«|------------  [ C )-
Fig. 1 PAB1 constructs as discussed in the manuscript. Residues for 
each domain are indicated at the top. PAB 1-184 has residues 
184DAL186 replaced with EKM, PA B1-180 has residues 180KE181 
with ER (not shown in the figure), and PA B-134 has 134HPD136 
replaced with DKS (Otero et al. 1999)
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experiments in our studies so as to eliminate many non­
specific interactions that might have been detected. We 
also incorporated the analyses of PABl deletion deriva­
tives to identify possible PABl-specific domain interac­
tions. We identified 55 proteins that associated with PABl, 
the vast majority of which would be expected to be in the 
presence of PAB 1 and mRNA due to their known roles in 
RNA metabolism. Using PABl deletion derivatives, we 
delimited this group of 55 proteins to 13 proteins that 
interacted with PABl dependent on one specific PABl 
domain or another. Four of the six previous known specific 
PABl domain interactors were found in this group of 13 
proteins, confirming the validity of this approach. We 
extended this analysis by verifying that UPF1 did interact 
with PABl through the RRM1 domain. The RRM1 
domain, in turn, while important for UPF1-induced dead­
enylation in nonsense-mediated decay (NMD), was not 
required for the more critical decapping step in NMD.
Materials and methods
Yeast strains and growth conditions
The parental yeast strain AS319/YC504 (MATa ura3 leu2 
trpl his3 pabl::HIS3 (YC504-Flag-PABl-TRPl) was gen­
erally used for Flag pull-downs and mass spectrometric 
analyses. Different PABl variants, as indicated in Fig. 1 
and the text, were swapped into this strain using standard 
genetic methods (Yao et al. 2007). The strain carrying the 
cdc33-l allele (AS1881/YC504) was isogenic to this strain. 
For one series of mass spectrometric analyses with the 
seven different deletion derivatives of PABl, strain 
1773-10 was used whose genotype was the same as AS319/ 
YC504 and is 75 % congenic with AS319/YC504. For the 
control experiments AS319/YC360 was used (isogenic to 
strain AS319/YC504 except for carrying plasmid YC360- 
PAB1-URA3 instead of plasmid YC504) (Yao et al. 2007). 
For the UPF1-PAB1 protein analysis, strain AS319/YC504 
(PABl-wt) or/YC505 (PAB1-ARRM1) was transformed 
with plasmid pRS315 (HA-UPF1-LEU2) or pRP910 
(UPF1-LEU2). Deadenylation assays were conducted in the 
UPF1 background with strains AS319/YC504 and AS319/ 
YC505 each transformed with plasmid pRP469 (PGKlpG  
URA3) or pRP1078 (PGKlpG-319 URA3) and in the upflA  
background with strains RR27-1 (Mata ura3 leu2 trpl his3 
pabl::his3::Neo upfl A:\HIS3) carrying the YC504, YC505, 
and PGK1 plasmids as described for AS319.
Yeast strains were routinely grown on minimal medium 
supplemented with 2  % glucose and the appropriate amino 
acids (Yao et al. 2007). For the RNA pulse-chase experi­
ments, the initial growth of cells was in medium containing 
2  % sucrose.
Mass spectrometric analysis
Flag immunoprecipitated extracts were fractionated by 
SDS-PAGE prior to trypsin digestion of gel slices across 
the gel lane as described (Kristensen et al. 2008). Tandem 
mass spectrometry (LC MS/MS) was used for peptide and 
protein identification as previously described (Andersen 
et al. 2002; Gruhler et al. 2005).
Protein immunoprecipitations
Flag pull-down experiments conducted either for Western 
analysis or for mass spectrometric analysis were conducted 
as previously described (Liu et al. 1998; Yao et al. 2007). 
RNase A (0.1 mg/mL) treatment of extracts was conducted 
for 30 min prior to the treatment o f the extracts with Flag 
beads. For Western analysis, 50 mL cultures were routinely 
used. For the mass spectrometric studies, 300 mL cultures 
were used. The HA immunoprecipitations were conducted 
in a manner similar to that described for the Flag 
immunoprecipitations.
RNA analysis
Pulse-chase analyses for the GALl-PGKpG  mRNA were 
conducted as previously described (Lee et al. 2010; Tucker 
et al. 2001; Cao and Parker 2003). Briefly, after growth of 
cells in non-inducing medium containing 2  % sucrose, the 
mRNA was induced for 10 min with 2 % galactose and 
the mRNA expression was shut off with 4 % glucose. At 
the time points indicated, the RNA was isolated and sub­
jected to Northern analysis following polyacrylamide gel 
electrophoresis. The oligo(A) lengths were determined 
using the following standards: the length of the completely 
deadenylated PGK1 poly (A) tail (dT sample), the length of 
the deadenylated PGK1 fragment, and the length of the 
completely undeadenylated poly(A) tail at time zero based 
on other experiments using different GAL1 poly(A) tail 
lengths as standards. All pulse-chase experiments were 
conducted at least in duplicate.
Results
Purification of proteins associating with PABl using 
Flag-PABl derivatives
Prior to conducting mass spectrometric studies on PAB1- 
associated proteins, we assessed whether proteins known to 
be associated with PABl could be co-purified using a 
PABl tagged at its N-terminus with the Flag peptide (Yao 
et al. 2007). Following purification of Flag-PABl, both 
eIF4Gl and eIF4E were found to co-elute with PABl
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Fig. 2 PABl regions involved in binding eIF4G and eIF4E. Cell 
extracts from strains carrying only the Flag-PABl variants as 
indicated were bound to Flag beads, eluted with Flag peptide, and 
detected by western analysis using the antibodies as indicated in the 
figure. eIF4G refers to eIF4G l, as the antibody does not recognize 
eIF4G2, The asterisk in lane 3, left, refers to the PAB1-ARRM1 
protein band. The major band above it is a non-specific species that 
binds to the Flag antibody, a  All strains carried either a Flag-PABl 
derivative as indicated (lanes 2-11) o r PA B l alone (lane 1). b  Flag- 
PABl derivatives were expressed in strains carrying either wild-type 
CDC33 (lanes 1 and 4) or cdc33-l (lanes 2, 3, and 5)
(Fig. 2a, lane 2). Removal of RRM2 from PABl dimin­
ished eEF4Gl co-elution and reduced eIF4E association 
(Fig. 2a, lane 4), as previously demonstrated using in vitro 
binding assays (Kessler and Sachs 1998). In addition, we 
showed that the PAB 1-184 protein, carrying mutations in
amino acids 184—186 o f RRM2 that fails to bind eIF4G in 
vitro (Otero et al. 1999), resulted in reduced eIF4Gl 
binding to PABl but did not eliminate it (Fig. 2a, lane 10). 
Similar results, albeit not as dramatic as observed for 
PAB 1-184, were obtained for PAB 1-180, which mutated 
residues 180,181 (Otero et al. 1999) (Fig. 2b, lane 4). In 
contrast, other point mutations in PABl such as PAB 1-134 
that affects an unknown translation process of PABl (Otero 
et al. 1999; Ohn et al. 2007) and PAB1-F170V that affects 
PABl binding to poly (A) (Deardorff and Sachs 1997; Yao 
et al. 2007) did not have any effect on eIF4E or eIF4Gl 
binding (Fig. 2a, lanes 11 and 9, respectively). These 
results indicate that our purifications of Flag-PABl are 
capable of recapitulating PABl-specific interactions that 
have been studied previously. However, our analysis of 
interactions present in crude extracts between PABl and 
eIF4Gl was found to be more robust than those observed in 
vitro, suggesting that in vivo the contact between PABl 
and eIF4Gl is not stabilized by a simple single interaction.
Isolation of Flag-PAB 1 from a strain carrying the cdc33- 
1 allele (encoding an eIF4E protein that is defective for cap 
binding at 37 °C but that is stably expressed) (Altmann 
et al. 1989), reduced both the eIF4E and eIF4Gl associa­
tion with PABl (Fig. 2b, lane 2). Combining cdc33-l with 
either PAB 1-184 or PAB 1-180 (Fig. 2b, lanes 3 or 4) 
severely interfered with eEF4Gl and eIF4E binding to 
PAB 1. It should be mentioned that eEF4A was not found to 
be present in our Flag-PABl immunoprecipitations as 
assessed by Western analysis (not shown). This result is 
expected, as eEF4A from yeast is known to be transiently 
associated with the eIF4F complex that contains eIF4G and 
eIF4E (Neff and Sachs 1999; Von der Haar and McCarthy 
2002; Pause et al. 1994; Yoder-Hill et al. 1993).
Rationale for using mass spectrometric analysis 
to identify PABl-mRNP protein contacts to specific 
PABl domains
Our rationale for identifying the most likely bona fide protein 
contacts either with PABl or within the context of the PABl- 
mRNP structure was as follows. While a number of proteins 
are known to associate with PABl through previous mass 
spectrometric experiments (Gavin et al. 2002; Ho et al. 2002), 
the specificity of proteins interacting with PABl or its 
domains could not be determined. We sought to significantly 
bypass this limitation by delimiting contacts to specific 
domains of PAB 1, thereby identifying the specificity of these 
interactions suggestive of their directness. This analysis 
would begin to approximate the bona fide PABl proteome. 
The identification of specific domains of PABl used in these 
contacts also would allow internal verification of the validity 
of the approach since a few proteins have been shown to bind 
to specific PABl domains (Table 1).
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Two types of control experiments (done at least in dupli­
cate) were conducted to eliminate contaminating proteins 
from the list of proteins interacting with PAB 1. The first was 
to conduct mass spectrometric analysis on Flag bead purified 
material from a strain with PABl without the Flag tag. The 
second was to conduct mass spectrometric analysis on Hag 
bead purified material extracted from strains carrying the 
Hag-PABl following an extensive RNase A treatment. 
RNase A treatment eliminates PABl binding to the 
poly(A) tail, allowing us to identify only those proteins that 
associated with PAB 1 within the context of the PAB 1-mRNP 
structure (Yao et al. 2007). Each control experiment was 
conducted with strains carrying either wild-type PABl 
(without the Hag tag) or with Hag-PABl (RNase A treat­
ment) and compared with Flag-PABl (no RNase A treat­
ment). The number of unique peptides detected for each 
protein present following the Flag pull down experiment 
rather than the number of total peptides detected was com­
pared between these samples. Significant bias can be intro­
duced with the counting of the total peptides due to the fact 
that certain peptides are more readily detected by mass 
spectrometric analysis than other peptides (Fleischer et al. 
2006). Proteins that were not present in the control samples 
and which were present in the arbitrary cut-off of greater than 
40 % of the experimental samples with Hag-PABl were 
considered to be likely PABl-associated proteins. Table 2 
lists these 44 proteins, the average number of unique peptides 
observed in each case, their protein abundance factor (PAF), 
and the most likely function related to PABl. A PAF value 
represents the average number of unique peptides observed 
divided by the molecular weight of the protein (lOx kDa). 
The PAF value normalizes the number of unique peptides to 
the size of the protein, which, in turn, is proportional to the 
number of possible tryptic peptides that could be observed in 
the experiment (Heischer et al. 2006). An additional nine 
proteins interacted with PABl in 40 % or less of the mass 
spectrometric experiments (Table 3). However, the PAF 
score for these proteins was uniformly at the lower end when 
compared with the list presented in Table 2, supporting our 
limiting the most likely PAB 1 interacting proteins to those in 
Table 2.
Comparison of our identified PAB 1 interactors 
with known PABl protein contacts
We judged that our analysis was detecting and identifying 
specific PABl-mRNP contacts by three means. First, the 
summary of two different TAP mass spec analyses of the 
yeast proteome (Collins et al. 2007; Ho et al. 2002; Gavin 
et al. 2002) have identified 41 significant non-ribosomal 
protein contacts to PABl. Of the top 12 proteins on this 
list, we identified 8  o f these (eIF4Gl, eIF4G2, CBC1, 
NAB6 , NAB3, SGN1, GBP2, and CBF5).
Second, the direct interactions of PABl with other 
proteins have been studied by other biochemical proce­
dures. Translation initiation factors eIF4Gl and eDF4G2 are 
known to contact PABl through its domains RRM1 and 
RRM2 (Tarun and Sachs 1996; Otero et al. 1999), eRF3, 
involved in translation termination, is known to contact 
PAB 1 through its C domain (Gorgoni and Gray 2004), and 
PBP2 is known to contact PA Bl through either the P or C 
domain (Mangus et al. 1998). All four of these proteins 
were found in our group of 44 proteins associating with the 
PABl-mRNP structure.
Third, our list of 44 proteins contains 38 proteins that 
would be expected to associate with the PABl-mRNP 
complex. There are nine proteins involved in translation, 
three in mRNA decay, seven in RNA binding, three in 
mRNA transport, one in splicing, and another fifteen pro­
teins in nucleolar and/or ribosomal biogenesis, all pro­
cesses known to include PABl (Table 2) (Peng et al. 2003; 
Brune et al. 2005; Yao et al. 2007). Only six other proteins 
were identified that play no obvious roles related to that of 
PABl.
Identification of proteins that interacted with specific 
PABl domains
Because the above list of 44 possible and known PAB1- 
associated proteins may contain proteins that are part of the 
PABl-mRNP structure but are not dependent on binding 
PABl through any of its domains, we wished to further 
delimit this group by identifying those proteins that inter­
acted through a specific PABl domain. To identify specific 
protein contacts to different domains of PABl, mass 
spectrometric analysis was conducted on all the proteins 
that co-purified with each o f seven Hag-PAB 1 derivatives 
(PABl, -ARRM1, -ARRM2, -ARRM3, -ARRM4, -AP, 
-AC; see Fig. 1). Each strain carried only the Flag-PABl 
derivative as indicated, for the genomic PABl gene that 
had been deleted (Yao et al. 2007). Prior to mass spec­
trometric analysis, the resultant immunoprecipitations were 
shown to contain equivalent amounts of each PABl 
derivative as detected by Western analysis (data not 
shown). Each of these derivatives have been extensively 
characterized for effects on poly(A) binding, mRNA 
export, translation, deadenylation, and decapping (unpub­
lished observation) (Yao et al. 2007; Brune et al. 2005; 
Dunn et al. 2005; Kessler and Sachs 1998; Simon and 
Seraphin 2007), and they do not result in severe growth 
defects. All PABl derivatives were assayed for general 
effects on in vivo protein synthesis (Yao et al. 2007; Ohn 
et al. 2007) and for effects on ribosomal and polysomal 
abundance. No specific effects on 80S ribosomal and 
polysomal abundance were observed with any of the PABl 
deletions (data not shown). In terms of global protein
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Table 2 Proteins that associated with wild-type PAB 1
Protein Mol. wt. (kDa) Unique peptides (Avg.) PAF score Function related to PABl
UTP20 288 13 0.45 Nucleolar
URB1 204 2.6 0.13 Nucleolar
RRP5 194 50 2.6 Nucleolar
RPA190 188 10 0.53 Transcription
RLR1 185 15 0.81 THO complex
XRN1 176 40 2.3 * mRNA degradation
SKI3 165 8.6 0.52 mRNA degradation
yLR419w 164 10 0.61 RNA helicase
RSE1 155 3.2 0.21 Splicing
CLU1 145 9.8 0.68 Translation initiation
SSD1 140 19 1.4 RNA binding
NAB6 127 11 0.87 RNA binding
YEF3 117 6.0 0.51 Translation
RRP12 114 13 1.1 Nucleolar
UPF1 110 14 1.3 mRNA degradation
eIF4G l 107 31 2.9 Translation initiation
MIS1 107 12 1.1 Mitochondrial
eIF4G2 104 13 1.2 Translation initiation
UBP3 102 3.0 0.29 Nucleolar
CBC1 99.7 14 1.4 RNA binding
NAB3 90.5 2.6 0.29 RNA binding
yGR250c 89.7 7.0 0.78 Translation
ENP2 82.0 2.1 0.26 Nucleolar
NOP77 78.1 7.0 0.90 Nucleolar
eRF3 76.9 12 1.5 Translation
yGR054w 71.8 5.6 0.78 Translation initiation
yIL055c 70.8 4.0 0.56 Unknown
KRI1 68.6 3.6 0.52 Nucleolar
AEP2 68.1 7.4 1.1 Mitochondrial
NUG1 57.8 3.8 0.68 Nucleolar
CBF5 55.2 8.4 1.5 Nucleolar
SLF1 50.9 5.0 0.98 Translation
HRB1 49.3 4.0 0.81 mRNA export
GBP2 49.0 8.4 1.7 mRNA export
PUB1 48.0 4.6 0.96 RNA binding
TMA46 46.3 3.2 0.69 Translation
PBP2 45.6 5.7 1.2 RNA binding
KRR1 37.4 3.8 1.0 Nucleolar
RLP7 36.7 2.7 0.74 Nucleolar
BRX1 33.7 2.6 0.77 Nucleolar
LHP1 32.2 5.3 1.6 Nucleolar
SGN1 30.0 4.6 1.5 RNA binding
NOP6 25.2 3.3 0.13 Nucleolar
MNP1 20.6 1.4 0.68 Mitochondrial
Average number of unique peptides identified by mass spectrometric analysis across all wild-type PA B l pull-downs for proteins not present in 
the control experiments. Proteins in the list were identified in greater than 40 % o f the mass spectrometric experiments (5-7). The PAF score is 
the average number of unique peptides divided by MW (kDa) x  10. Protein names in bold were also present in greater than 40 % o f the mass 
spectrometric pull-downs across all PA Bl deletion derivatives (Table 4). Nucleolar refers to proteins that are found in the nucleolus or play a 
role in rRNA biogenesis
*£] Springer 72
Mol Genet Genomics (2012) 287:711-730 717
Table 3 Proteins that associated with wild-type PA B l in 40 % or less o f the mass spectrometric experiments
Protein Mol. wt. (kDa) Unique peptides (Avg.) PAF score Function related to PABl
RPB1 192 2.4 0.12 Transcription
TOP2 164 4.2 0.090 DNA metabolism
SKI2 147 2.2 0.15 mRNA degradation
RMD11 131 2.8 0.21 Unknown
MAK21 117 2.2 0.19 Nucleolar
PWP1 64 0.8 0.12 Nucleolar
AEP1 60 2.6 0.43 Unknown
PRP4 53 0.6 0.11 Splicing
NSR1 27 0.6 0.22 Nucleolar
Average number of unique peptides identified by mass spectrometric analysis across all wild-type PA B l pull-downs for proteins not present in 
the control experiments. Proteins in the list were identified in 40 % or less of the mass spectrometric experiments. O ther terms are defined in 
Table 2. Proteins yER138c, SOV1, and MRD1 were also identified in these mass spectrometric experiments, but since they were not identified 
in the wild-type pull-downs when the controls were conducted, they are not included in the list
synthesis, deleting either RRM1 or RRM2 had the most 
general effects: 28 % reduction by ARRM1 and 15 % by 
ARRM2, whereas the other deletions had insignificant 
effects. These effects by RRM1 and RRM2 deletions are, 
however, not overly severe, for in contrast, the cdc33-l 
(eIF4E) or prtl-46  (eIF3b) alleles block translation by at 
least 70 % (Yao et al. 2007; Ohn et al. 2007). The RRM1 
and P domains are known to be required for general and 
regulated deadenylation, and RRM3 restricts the dead­
enylation process (Yao et al. 2007; Lee et al. 2010; Simon 
and Seraphin 2007). Deletion of the RRM4 domain, but not 
other domains, also appears to play some role in mRNA 
export from the nucleus (Brune et al. 2005; Simon and 
Seraphin 2007) (see Table 1 for a summary of these pre­
viously known interactions).
Following our mass spectrometric analysis done in 
duplicate for each PABl derivative, the number of unique 
peptides of proteins associated with a particular PABl 
variant was determined. Only those proteins (not present in 
the control experiments described above) which were 
found to be associated with at least 1  derivative in both 
duplicate analyses and which were present in greater than 
40 % of the total of 14 PABl derivative mass spectro­
metric analyses were considered as likely PABl interacting 
proteins. This group of 43 proteins overlapped significantly 
with the proteins identified only in the wild-type PABl 
Flag pull downs described above: 32 were present in both 
sets (Table 4). The 11 new proteins found to be associated 
with the majority of PABl deletion derivatives included 
1 RNA binding protein involved in translation and mRNA 
degradation (SBP1), 2 proteins in mRNA splicing 
(RAI1, and SMB1), 3 nucleolar/RNA biogenesis proteins 
(MAK21, GAR1, and NHP2), 2 mitochondrial mRNA 
splicing proteins (CBP2 and MSS 116), and 3 other proteins
(RMD11, MPD1, and an unknown protein). An additional 
eight proteins interacted in 40 % or less of the mass 
spectrometric experiments (Table 5) but were judged less 
likely to be associated with PA Bl, as, again, their PAF 
scores were' extremely low.
Of the 43 proteins that specifically co-immunoprecipi- 
tated with the various PABl deletion derivatives, the 
average number of unique peptides found for each PABl 
derivative was compared across the derivatives. Those 
PABl-associated proteins that displayed twofold differ­
ences in peptide abundance (Table 6 ), as compared to wild- 
type PA Bl, were initially judged as displaying possible 
specific contacts to one or another of the PABl domains. 
By this criterion, only 13 proteins were affected in their 
binding to one or another o f the PABl domains (Table 6 ). 
Of these 13 proteins, we identified several proteins that 
previous biochemical studies have demonstrated or sug­
gested to make specific contacts to one or another of the 
PABl domains. eIF4Gl and eIF4G2 are known to contact 
PABl through at least the RRM1 and RRM2 domains 
(Tarun and Sachs 1996; Otero et al. 1999) with RRM2 
being most critical, which we have confirmed (Table 6 ). 
eRF3, involved in translation termination, is known to 
contact PABl through its C domain (Gorgoni and Gray 
2004), an observation we confirmed and extended by 
indicating that the P region was also important to this 
contact. Finally, PBP2 is known to contact PABl through 
either the P or C domain (Mangus et al. 1998), and we 
established that it is the C region and not the P domain that 
was critical for this interaction. These correspondences and 
extensions indicated that the methodology we were using 
was consistent with published biochemical analyses. 
Importantly, these similarities indicate that the specific 
domain interactions we were observing for the other nine
73 <£) Spring er
Ifit Table 4  Proteins that interacted with PABl and its deletion derivatives
Protein Mol. wt. (kDa) Unique peptides (Avg.) PAF score Function related to PABl
UTP20 288 5.7 0.2 Nucleolar
RRP5 194 41 2.1 Nucleolar
RPA190 188 4.1 0.22 Transcription
RLR1 185 12 0.68 THO complex
XRN1 176 46 2.6 mRNA degradation
SKI3 165 2.9 0.17 mRNA degradation
yLR419w 164 16 0.95 RNA helicase
RSE1 155 3.4 0.22 Splicing
SSD1 140 10 0.75 RNA binding
RRP12 138 5.3 0.38 Nucleolar
RMD11 131 2.4 0.18 Nitrogen regulation
NAB6 127 13 1.0 RNA binding
YEF3 117 1.8 0.15 Translation
MAK21 117 2.3 0.2 Nucleolar
UPF1 110 20 .1.8 mRNA degradation
eIF4G l 107 38 3.6 Translation
MIS1 107 3.3 0.31 Mitochondrial
eDF4G2 104 17 1.7 Translation
CBC1 100 12 1.2 RNA binding
NAB3 90 2.1 0.23 RNA binding
yGR2S0c 90 6.4 0.72 Translation
NOP77 78 8.6 1.1 Nucleolar
eRF3 77 10 1.4 Translation
MSS 116 77 3.6 0.48 Mitochondrial
CBP2 74 1.0 0.14 Mitochondrial splicing
ylLOSSc 71 5.3 0.75 Unknown
CBFS 55 3.4 0.62 Nucleolar
SLF1 51 4.7 0.93 Translation
GBP2 49 10 2.1 mRNA export
TMA46 46 1.3 0.28 Translation
PBP2 46 9.2 2.0 RNA binding
RAI1 45 1.3 0.29 Splicing
RLP7 37 2.1 0.56 Nucleolar
MPD1 37 1.2 0.33 Chaperone
BRX1 34 1.8 0.53 Nucleolar
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proteins (NAB6 , UPF1, SSD1, CBC1, GBP2, CBF5, SLF1, 
NOP77, and yGR250c) were very likely to be valid. It 
should be noted that while NOP77 appears to interact 
through RRM1 of PA Bl, there appears sufficient vari­
ability in all o f its interactions with PABl deletion deriv­
atives to place less confidence on this particular 
identification.
To further assess the importance of the differences we 
observed in the interactions of certain PABl deletion 
derivatives with the particular proteins listed in Table 6 , 
we analyzed the intensities o f  specific peptide species that 
were co-immunoprecipitated with each PABl deletion 
derivative. Intensity refers to the number of times a par­
ticular peptide was detected in the mass spectrometric 
experiment. In this case, if a protein interacted through a 
particular PABl domain, then specific peptides of that 
protein should be decreased or absent for the mass spec­
trometric analysis conducted with that PABl deletion 
derivative when compared across all PABl deletion 
derivatives. By analyzing particular peptide species across 
the mass spectrometric data for the PABl deletion deriv­
ative pull downs, we would not be creating a bias in terms 
of the ability of the mass spectrometer to detect a particular 
peptide species. This analysis was, however, limited to 
only those peptides for a particular protein that were 
identified amongst most, if  not all, PABl deletion analyses. 
This analysis could not be confidently done for the fol­
lowing proteins because o f the low level o f unique peptides 
identified across most PA Bl deletion derivatives: CBC1, 
CBF5, SLF1, eRF3, NOP77, and yGR250c.
Table 7 lists the intensity averages for the peptides of 
each protein interacting with specific PABl deletion 
derivatives. For example, o f  the 14 peptides of eIF4Gl that 
were identified in this analysis, significant less eIF4Gl 
peptide intensities were observed in the mass spectrometric 
studies with PABl derivatives deleted for RRM2 or RRM1 
when compared to the experiments done with the other 
deletion derivatives. This result is consistent with the above 
identification of RRM1 and RRM2 as being important to 
the PABl contact made by eIF4Gl based on the average 
number of unique peptides identified in the mass spectro­
metric analysis (Table 6 ). Similarly, eIF4G2 displayed 
reduced peptide intensities in the pull-down experiments 
with the RRM1 and RRM2 deletion derivatives. Signifi­
cantly, however, eIF4G2 did not display reduced intensities 
of particular peptides for the P domain deletion of PABl, 
although eIF4G2 had a reduction in the average number of 
unique peptides identified in the P domain deletion deriv­
ative as compared to other domains deletions (Table 6 ). 
Therefore, the P domain o f PABl is not likely to be a 
specific region through which eIF4G2 acts. As controls for 
these sets of analyses, proteins, such as XRN1, RRP5, 
RLR1, and yLR419w, which did not display differences in
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Table 5 Proteins identified in 40 % or less o f the mass spectrometric experiments conducted with the PA B l deletion derivatives
Protein Mol. wt. (kDa) Unique peptides (Avg.) PAF score Function related to PABl
GCNl 298 2.5 0.083 Translation
RPB1 192 0.36 0.018 Transcription
SK32 147 0.64 0.044 mRNA degradation
RPC82 74 1.2 0.16 Transcription
UTP15 58 0.21 0.036 Nucleolar
RPC34 36 0.28 0.077 Transcription
RPB5 26 0.28 0.11 Transcription
SLX9 25 0.43 0.17 Unknown
The proteins PRP8, POL2, yER138c, TOP2, and RATI were detected in several o f the mass spectrometric experiments but were not included in 
the list because they were not detected in the wild-type pull-downs when the control experiments were conducted
Table 6 Average number o f unique peptides identified for proteins co-purifying with PA Bl
Protein PA B l-w t ARRM1 ARRM2 ARRM3 ARRM4 AP AC
PABl 66 68 70 66 68 60 70
eIF4Gl 50 20 16 46 46 42 42
eIF4G2 25 10 7 24 20 10 24
UPF1 26 8 22 21 22 18 24
CBC1 18 13 I7 12 7 2 16
NAB6 14 6 10 12 20 18 17
eRF3 14 8 20 14 8 2 6
PBP2 12 14 10 11 11 7 0
SSD1 10 16 11 4 13 8 10
NOP77 10 5 13 8 6 9 10
GBP2 10 4 6 14 10 12 16
SLF1 8 2 5 4 3 3 8
CBF5 4 4 2 4 0.5 2 4
yGR250c 3 6 13 6 12 0.5 6
Mass spectrometric analysis on proteins co-purifying with individual Flag-PABl variants was conducted as described in the text. Only those 
proteins that are listed in Table 4  were compared. Values refer to the average number of unique peptides detected for each protein for the two 
series of experiments that were conducted. Values in bold displayed significant differences (at least two-fold differences in values as compared to 
the wild type)
binding PABl deletion derivatives based on comparing 
unique peptides also showed no differences when the 
intensities of individual peptides associating with the 
PABl deletion derivatives were compared (see legend for 
Table 7).
The intensity analyses for the peptides of other proteins 
interacting with specific domains of PABl confirmed that 
SSD1 interacted through RRM3, GBP2 through RRM1, 
PBP2 through the C domain, and NAB6 through the RRM1 
domain (Table 7). However, for NAB6 the data also indi­
cate that the RRM2 domain may play some role in binding 
it. Overall, the analysis of the intensity differences for 
particular peptides supports the assignment of PABl
domains for being important in interacting with specific 
proteins based on the number o f unique peptides observed 
in the mass spectrometric analyses (Table 6).
UPF1 interaction with PABl requires the RRM1 
domain but not the C-terminal region of PABl
Based on our mass spectrometric studies, we chose to 
further investigate the putative UPF1 interactions with 
PABl, as mammalian studies had indicated that UPF1 
controls NMD in an interaction with termination factor 
eRF3 that, in turn, restricts binding of PABPC1 to eRF3 
(Brogna and Wen 2009). Such an interaction suggests that
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Table 7 Average of individual peptide intensities for proteins associating with PA Bl deletion derivatives
Protein PABl PAB1-ARRM1 PAB1-ARRM2 . PAB1-ARRM3 PAB1-ARRM4 PAB1-AP PABl-AC
eIF4Gl 100 7.4 (4.7) 3.9 (1.1) 120 (29) 110 (16) 140 (28) 160 (30)
eIF4G2 100 8.6 (4.7) 25 (13) 74 (26) 210 (25) 110 (50) 72 (30)
NAB6 100 3.8 (3.7) 23 (5.2) 62 (9.0) 130 (20) 100 (20) 94 (23)
PBP2 100 300 (160) 150 (31) 130 (9.0) 260 (21) 220 (60) 0 (0)
SSD1 100 110 (45) 53 (20) 22 (3.5) 170 (42) 180 (44) 190 (90)
GBP2 100 0(0) 42 (13) 81 (28) 65 (19) 120 (18) 94 (24)
Mass spectrometric analysis was conducted as described in Table 6. The intensities for the peptides for each individual protein described in Table 6 were 
compared across the PABl deletion derivatives. Peptides that were represented in all or nearly all Flag-PABl deletion derivative pull-downs were 
considered “good" peptides for cross comparisons of peptide intensities. For several proteins no peptides were found in a particular Flag-PAB 1 deletion 
derivative pull-down, but the peptide was retained in the “good” data set if this absence correlated with the domain that was suggested for interacting with 
the protein based on the results in Table 6. For eIF4Gl, 14 peptides were identified as “good’ peptides; for eIF4G2, there were 4 peptides; for NAB6, there 
were 4 peptides; for PBP2, there were 3 peptides; for SSD1, there were 4 peptides; and for GBP2, there were 3 peptides. One or no “good” peptides were 
identified for the other proteins listed in Table 6. The relative intensities were normalized to 100 for PABl, wt, and the value given in the table is the 
average of these values for all of the peptides for each protein. Standard errors of the mean are given in parentheses where applicable. As additional 
controls, analysis of average intensities for “good” peptides for several proteins not listed in Table 6 but which were included in Table 4 as not associating 
with PABl through any particular domain demonstrated no differences in intensities across the various PABl deletion derivative pull-downs (RLR1, 
RRP5, yLR419w, and XRN1 were analyzed)
it is the C-terminal domain of mammalian PAB PCI that 
would be important to UPF1 interactions, in contrast to the 
RRM1 domain as suggested by our studies for yeast PABl.
To examine UPF1 and PABl interactions further, we chose 
to study them in the reverse direction. By first using an 
HA-tagged UPF1 protein to purify UPF1 from yeast cells, 
we then queried whether PABl or PAB1-ARRM1 could be 
co-immunoprecipitated. As displayed in Fig. 3, immuno- 
precipitation of HA-UPF1 was capable of immunoprecip- 
itating Flag-PABl but was unable to co-immunoprecipitate 
Flag-PAB 1-ARRM1 (compare lane 3-4). These results 
confirm the mass spectrometric analyses described above.
Importantly, the truncated form of PABl (PAB1-T) (lane 
3), which is missing both the P and C domains of PABl 
(mass spectrometric analysis o f PAB1-T indicated that the 
truncation occurs between residues 496 and 506 of PABl, 
unpublished observation), was quite able to interact with 
HA-UPF1. Therefore, PABl requires its RRM1 but not its 
P or C domain to interact with UPF1.
The RRM1 domain of PABl is required for UPF1- 
dependent NMD deadenylation but not decapping
If the interaction between PABl and UPF1 were to be 
physiologically important, we might expect that the RRM1 
domain of PAB 1 would play a role in UPF1 -mediated NMD.
However, a previous study indicated that deletion of PAB 1 
from yeast does not impair the NMD process (Mieux et al.
2008). As NMD consists of the acceleration o f two separable 
steps in the degradation of mRNA, decapping and dead­
enylation (Cao and Parker 2003), it remains possible that 
PAB 1 is not required for the major part of NMD (decapping) 
but plays a role in the secondary process of deadenylation.
Previous results have also established that PABl deletion
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Fig. 3 UPF1 imm unoprecipitates PA B l through the PA B l RRM1 
domain. HA-UPF1 pull-downs were conducted as described in Fig. 2. 
Flag-PABl (lanes 1 and 3) and its RRM1 deletion derivative ( lanes 2 
and 4) were identified using antibody directed against the Flag peptide 
and antibody directed against the HA epitope was used to detect HA- 
UPF1. Lanes 7, 2 crude extracts; lanes 3, 4 HA immunoprecipitations
derivatives have no effect on general decapping (Yao et al. 
2007) but that they are critical for deadenylation (Yao et al. 
2007; Lee et al. 2010; Simon and Seraphin 2007).
We consequently used pulse-chase analysis to test the effect 
of deleting the RRM 1 domain ofPA Bl on nonsense-mediated 
decay processes. These analyses used GAL1-PGK1 mRNA
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that was either wild-type or contained a nonsense mutation in 
residue 319 that subjects the mRNA to NMD (Cao and 
Parker 2003). Isogenic yeast strains carrying either Flag- 
PABl or Flag-PAB 1-ARRM1 with either GALl-PGKlpG  or 
PGKlpG-319 were pregrown in non-galactose inducing 
medium and then subjected to a brief induction of the GAL1 
promoter with the addition of galactose (the pulse), prior to 
shutting off of gene expression with glucose (the chase). 
Following extraction of RNA at various times after the 
shutoff of transcription, northern analysis was utilized to 
identify the PGK1 mRNA species present as a function of 
time. In Fig. 4a, using wild-type PABl and wild-type 
PGKlpG mRNA, PGKlpG  mRNA was deadenylated 
slowly in a basically distributive manner represented by the 
bulk of the deadenylated species moving as a relatively tight 
band in which it became progressively deadenylated. At 
about 8-12 min the 10 A ’s oligo(A) species that represents 
nearly completely deadenylated species began to become 
abundant and the tightness of the band became reduced, as 
deadenylation shifted from a primarily distributive to a 
processive mode (see top densitometric scan). A decapped 
PGK1 mRNA fragment that was deadenylated began to be 
visualized over background around 4—8 min and became 
quite abundant at later times at 20 min (see densitometric 
scans), indicative of extensive decapping once the 
oligo(A) species was formed. These results are very similar 
to those obtained previously for PGK1 mRNA (Decker and 
Parker 1993; Muhlrad et al. 1994; Tucker et al. 2001; Cao 
and Parker 2003). However, it should be noted that in our 
experiments a small amount of decapped and nearly fully 
deadenylated fragment is present at the zero time point, 
although its abundance is very low relative to the abundance 
of the full-length PGKlpG  mRNA at the same time.
As expected from previous studies (Cao and Parker 2003), 
in a wild-type PABl background the NMD target mRNA, 
PGKlpG-319, displayed much more rapid decapping and 
deadenylation, as evidenced in Fig. 4c. A significant abun­
dance of deadenylated and decapped PGKlpG-319 fragment 
appeared immediately and was in significant abundance as 
compared to that of the full-length mRNA (early time points). 
The increased ratio at early time points of decapped fragment 
to full-length mRNA for the PGK1-319 mRNA in compari­
son to the ratio for the wild-type PGK1 mRNA indicates 
much more rapid degradation of the PGK1 mRNA containing 
the premature termination codon, as expected. Moreover, 
scrutiny of the early time points also indicates that a signifi­
cant amount of the fragment displayed a large spread of 
poly(A) lengths from 70 A ’s to 10 A’s, indicative of rapid 
decapping regardless of the poly(A) tail length that was 
present (see densitometric scans at early time points). In 
addition, it can be observed that the full-length PGKlpG-319 
mRNA did not uniformly decrease in poly(A) length as a tight 
band as it had for the PGKlpG  mRNA (Fig. 4a). This is
consistent with a switch to primarily processive deadenyla­
tion in which full length poly(A) tails are present in the 
population along with completely deadenylated species.
In contrast to these results with wild-type PA Bl, deleting 
the RRM1 domain of PA Bl, blocked both normal deadeny­
lation of PGKlpG  and that of PGKlpG-319 (Fig. 4b, d, 
respectively). In the wild-type PGKlpG  mRNA situation, the 
RRM1 deletion blocked deadenylation in which no fragment 
accumulated (Fig. 4b). This result is consistent with dead­
enylation normally preceding decapping and being required 
for it (Decker and Parker 1993). For the PGKlpG-319 
mRNA, little apparent deadenylation of full-length PGKlpG- 
319 occurred, yet the PGK1 fragment appeared very rapidly, 
albeit immediately in the fully polyadenylated form. It should 
be noted that this fragment species did not represent the full- 
length mRNA species, for at later times it decreased notice­
ably to sizes smaller than the 0A form of the full-length 
mRNA version. Therefore, it corresponds to the PGK1 
fragment. In addition, both the full-length mRNA version and 
the fragment initially have more A ’s than are present in the 
wild-type PABl situation (compare Fig. 4b to that of a and 
Fig. 4d to that of 4c). This increased poly(A) tail length at 
initial times is due to the ability of the RRM1 deletion of 
PABl to block both CCR4 and PAN2 deadenylation (Yao 
et al. 2007) (data not shown). Blocking PAN2 deadenylation 
results in increased poly(A) tail lengths (Brown and Sachs 
1998). These results indicate that RRM1 of PABl does not 
impair NMD-induced decapping, but it is required for the 
NMD acceleration of deadenylation.
Because RRM1 is required for all deadenylation processes 
that have been analyzed, including those that are constitutive 
(Yao et al. 2007) and regulated (Lee et al. 2010), it remains 
possible that the presumed contact of UPF1 to that of the 
RRM1 o f PAB 1 has nothing specifically to do with regulating 
NMD-enhanced deadenylation. To explore this possibility 
further, we tested the requirement for RRM1 on deadenyla­
tion in an upfl A background. Using the same pulse-chase 
experimental strategy described above, we first analyzed the 
effect o f the upfl A on PGK1 mRNA deadenylation. In this 
case, the mRNA became deadenylated at initial times nearly 
at the same rate as observed in the UPF1 background, with the 
oligo(A) species becoming present at around 12 min after the 
transcriptional shutoff (Fig. 5a). However, it should be noted 
that the distribution o f poly(A) tails is significantly different 
between the UPF1 and the upfl A  backgrounds. The 
poly(A) tail distribution in the upfl A background remained 
tighter at all time points, indicative of a primarily distributive 
deadenylation pattern (see densitometric scans for additional 
clarity). Importantly, there was no shift to the processive 
pattern that was apparent with the UPF1 background at time 
points after 8 min as observed in Fig. 4a. This upfl A effect on 
the spread of poly (A) tail lengths during deadenyltion is the 
same as previously published, albeit unremarked upon at the
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Fig. 4  Transcriptional pulse-chase analyses on PGKI mRNA were 
conducted as previously described (Lee e t al. 2010). Following 
induction o f the G A Ll-P G K l mRNA with galactose, transcription 
was shut off with glucose and, at the times (in min) indicated above 
the figure, RNA was extracted and northern analyses were conducted 
as described (Yao et al. 2007). dT refers to the RNA sample probed 
with oligo (dT) followed by RNase H digestion to remove the poly 
(A) tail. Equivalent amounts o f RNA were loaded into each lane 
across a panel, as determined by A26o spectrophotometric analysis, a, 
c Strain AS319/YC504 (wild type for PA B l); b , d strain AS319/ 
YC505 (PAB1-ARRM1). a, b. Strains were transformed with pRP469 
carrying the PGKlpG  wild-type gene; c, d  strains were transformed
with pRP1078 carrying the P G K lpG -319  that has a nonsense 
mutation at amino acid 319 (Cao and Parker 2003). Densitometric 
scans of the data are presented to the right o f the northerns, a  Both the 
full-length and fragment scans are presented and in separate figures to 
ease identification o f the species. For the full-length scan in this case, 
the time points are given in reverse order to clarify visualization of 
the latter time points, b  Only the full-length densitometric scans are 
presented, as there were no identifiable fragments, c, d  Both full- 
length and fragment densitometric scans are presented, albeit in one 
continuous figure. For ease o f interpretation the right y  axis desig­
nations skip every other time points for clarity
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Fig. 4  continued
time (Cao and Parker 2003). These data suggest that UPF1 
may play a role in the switch from distributive to processive 
deadenylation, a process requiring PABl removal from the 
mRNA (Tucker et al. 2002; Viswanathan et al. 2003; Yao 
et al. 2007). In agreement with this observation, fewer 
deadenylated fragments were seen in the upfl A background 
in Fig. 5a as compared to the UPF1 background (Fig. 4a). 
This result is also the same as previously published (Cao and 
Parker 2003). This is consistent with fewer oligo(A) species 
being formed and subsequently decapped due to the reduction 
in processive deadenylation caused by the upfl A mutant.
In the case of NMD in a upfl A background, PGKI-319 
mRNA was deadenylated in a similar manner to that of the 
wild-type PGKI mRNA (compare Fig. 5c to a), as UPF1 is 
known to block NMD deadenylation. Little or no PGKI frag­
ment was observed, consistent with distributive deadenylation 
and little or no oligo( A) species were formed due to reduction in 
processive deadenylation (in long exposures of Fig. 5c only a 
very little abundance of the fragment was detected).
In the strain background deleted for RRM1, wild-type 
PGKI mRNA did not appreciably deadenylate, as expected
(Fig. 5b). Similarly, the RRM1 deletion significantly 
blocked PGK1-319 mRNA deadenylation (Fig. 5d). No 
PGKI mRNA fragments were observed in either case. 
These data suggest that RRM1 is required for deadenyla­
tion independent of the presence of UPFl. Other roles for 
the UPF1-RRM1 interaction, as in the switch from dis­
tributive to processive deadenylation, remain possible (see 
“Discussion”).
Discussion
Mass spectrometric identification of proteins interacting 
through specific PABl domains
We have used mass spectrometric techniques to identify a 
total of 55 non-ribosomal proteins that associate with 
PABl (Tables 2, 4). All but 11 of these proteins are likely 
components of RNA complexes or processes that involve 
PABl. Many of these proteins are RNA binding factors 
that would be expected to interact with the mRNA and
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Fig. 5 Effect o f upfl A on deadenylation. Pulse-chase experiments 
were conducted exactly as described in Fig. 4, except the following 
strain was used: RR27-1, a YC504/RP469 (PGKlpG)-, b  YC505/
RP469; c YC504/RP1068 (PG K lpG -319 ); YC505/RP1068. Densito­
metric scans are presented as described in Fig. 4
therefore would be part of the PABl-mRNP structure. A 
second large group of proteins that we found to be asso­
ciating with PABl are nucleolar and/or involved in ribo­
somal biogenesis. Previous mass spectrometric studies on 
nucleolar components have identified PA Bl, but it remains 
unclear as to the role that PABl plays in these processes 
(Mnaimneh et al. 2004; Staub et al. 2006; Krogan et al.
2004). There is some evidence, however, that PABl aids 
60S assembly to form a competent translation complex 
(Searfoss et al. 2001). Therefore, the types of proteins we 
have identified as associating with PABl support the 
validity of mass spectrometric approaches in defining 
PABl interacting components. However, similar to previ­
ous mass spectrometric studies, our list of proteins may not 
be specific to PABl and may be found to associate with 
PABl through very indirect RNA interactions.
We have endeavored to surmount the above limitation 
attached to global mass spectrometric studies using seven 
different PABl deletion derivatives in our analyses. In this 
case, by comparing the effect of well-defined domain
deletions in PABl to each other and to wild-type PABl, we 
were able to significantly shorten this list of 55 proteins 
associating with PABl to 13 factors. Of these 13 proteins, 
each was affected in its interaction with PABl for at least 
one of the PABl deletion derivatives. In validation of this 
methodology, we were able to identify four of the six 
previously known proteins that interact through specific 
PABl domains: eIF4Gl, eIF4G2, PBP2, and eRF3. Our 
results confirmed that the eIF4G proteins contact PABl 
through the RRM1 and RRM2 domains, extended the 
contact region of eRF3 to PABl to include the P domain, 
and delimited the PBP2 contact to PABl to just the C 
domain. Neither PBP1 nor PAN3, the other two proteins 
known to contact particular regions o f PABl (Mangus et al. 
1998; Hoshino et al. 1999), were found in any of our mass 
spectrometric analyses. In the case of PBP1, it has been 
shown recently to associate in PABl-mRNP complexes 
following the stress of glucose of deprivation in which 
particular stress granules are formed (Buchan et al. 2008). 
Unfortunately, our Flag-PABl immunoprecipitations do
81 45) Spring er
726 Mol Genet Genomics (2012) 287:711-730
upflA- PGK1-319
PAB1 wt














■  20 min 
•  30 mm
I3 n * i
Onto
Fig. S continued
not detect PABl in yeast stress granules (unpublished 
observation).
For the other nine proteins found to associate with one 
or another of the PABl domains, five of them, CBC1, 
GBP2, NAB6, UPF1, and CBF5, have been previously 
found to associate with PABl by mass spectrometric 
studies (Collins et al. 2007). CBC1 is the nuclear mRNA 
cap-binding protein (Das et al. 2000). Because PABl is 
known to be present in the nucleus, it is possible that the 
nuclear mRNA configuration also involves a closed-loop 
structure similar to that found for cytoplasmic mRNA 
involving eIF4E, eIF4G, and PABl (Wells et al. 1998). In 
the case of CBC1, it may make a direct contact to the 
RRM4 and P domains of PABl. This contact may not 
require an intermediary, as in the case of eIF4G bridging 
the cicularization of the mRNA by eDF4E and PABl. 
Because the RRM4 domain of PABl plays a role in mRNA 
transport from the nucleus (Brune et al. 2005), CBC1 
contact to this region of PABl may play an unknown role 
in this process.
GBP2 has been shown to be involved in mRNA trans­
port, translation, and stress granules (Buchan et al. 2008; 
Windgassen et al. 2004), all processes involving PABl. A 
role for RRM1, required for GBP2 interaction, in these
processes has not been identified, although deleting RRM1 
does have a significant, albeit not a large effect, on protein 
translation (Yao et al. 2007). Similarly, RRM1 is required 
for binding NAB6, an mRNA binding protein. NAB6 tends 
to bind mRNA involved in cell wall biogenesis (Hogan 
et al. 2008). Its RNA binding sites have, however, not been 
detected and the role of either PABl or its RRM1 domain 
in these processes is not clear. Similarly, the importance of 
the PABl RRM1 interaction with CBF5, a nucleolar pro­
tein involved in ribosomal biogenesis, is unknown. While 
the role of PAB 1 in binding these various proteins remains 
to be elucidated, the observation that these proteins 
repeatedly are found to associate with PABl and to do so in 
a domain-specific manner, strongly suggests that they are 
important PABl-associated factors.
The remaining four proteins, SSD1, SLF1, NOP77, and 
yGR250c, while not being previously shown to interact 
with PABl, are known to be involved in translation (SSD1 
and SLF1) (Sobel and Wolin 2006; Krogan et al. 2006), 
mRNA degradation (yGR250) (Windgassen et al. 2004), 
ribosomal biogenesis (NOP77) (Mnaimneh et al. 2004), or 
binding of eIF4E (SLF1) (Krogan et al. 2006), all pathways 
in which PABl has been directly linked. Several o f these 
proteins deserve special comment. GBP2 and yGR250c
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have been suggested to be components of yeast stress 
granules formed upon the stress of glucose deprivation 
(Buchan et al. 2008). While we have not been able to detect 
stress granule complexes with our Flag-PABl, it is possible 
that these two proteins also associate with mRNA trans­
lational complexes prior to stress granule formation. GBP2, 
in fact, is known to play roles in both mRNA export and 
translation (Windgassen et al. 2004). SSD1 is a known 
mRNA binding protein and possible RNase (Uesono et al. 
1997), and its sites of binding to the mRNA are very close 
to the 5' end of mRNA (Hogan et al. 2008; Ohyama et al. 
2010). Because this location is in the vicinity where eIF4E 
and eIF4G would interact to form the closed-loop mRNA 
structure with PABl (Wells et al. 1998), it is possible that 
SSD1 associates with PABl and the mRNA to form a 
closed-loop structure. Whether there are additional contacts 
to other translation factors such as eIF4G in this closed- 
loop configuration remains to be determined. SSD1 contact 
to PABl may therefore be a means to stabilizing its 
interactions with both the 5' and 3' ends of the mRNA. This 
may further advantage those particular cell wall encoding 
mRNAs that it may control (Kaeberlein and Guarente 
2002; Moriya and Isono 1999; Hogan et al. 2008) for 
optimal translation. Alternatively, SSD1 may suppress the 
translation of certain mRNA, such as CLN2, by binding to 
the 5' end of the mRNA (Ohyama et al. 2010; Jansen et al.
2009).
While our list o f proteins interacting indirectly or 
directly with PABl includes many of the processes in 
which PABl is known to be involved, several notable 
proteins are missing. For example, all components o f  the 
mRNA deadenylase complex (CCR4-NOT) were absent 
(Tucker et al. 2001; Chen et al. 2001, 2002; Cui et al.
2008). This is most likely due to the fact that most initial 
deadenylation of mRNA when PABl occupies two to three 
sites on the poly(A) tail takes place in a distributive manner 
(Yao et al. 2007; Decker and Parker 1993). In distributive 
deadenylation, CCR4 would not be stably bound to the 
PABl-mRNP complex. In contrast, processive deadenyla­
tion of poly(A) tails by CCR4, in which it would be more 
stably associated with the mRNA, requires more expansive 
naked poly(A) tails when PAB 1 would not be expected to 
be present (Tucker et al. 2002; Viswanathan et al. 2003). 
Proteins playing roles in mRNA decapping were also 
uniformly missing from our mass spectrometric analyses. 
In this case, decapping takes place in specialized P bodies 
(Sheth and Parker 2007), and previous studies have indi­
cated that PABl can associate with decapping proteins 
(Tharun and Parker 2001; Viela et al. 2000). Also, it has 
been reported that decapping can take place on translating 
ribosomes (Hu et al. 2009), in which case one would expect 
PABl to interact with decapping factors. Although PABl 
may be present in such complexes, we have no evidence
that our Flag pull downs can detect PABl in these com­
plexes. Other processes in which PABl is involved for 
which we did not identify PABl-associated proteins 
include that of mRNA export (Brune et al. 2005; Dunn 
et al. 2005; Chekanova et al. 2001) and 3' end processing 
(Hosoda et al. 2006; Amrani et al. 1997). Therefore, one 
limitation in our mass spectrometric studies is the inability 
to use a single bait to identify all possible protein com­
plexes in which a particular protein is present. Moreover, 
any differences that we observed between the proteins 
associating with PABl and proteins previously identified 
by mass spectrometric procedures may be due to the bait 
and conditions employed for obtaining protein complexes 
in the respective experiments.
Role of RRM1 of PABl in nonsense-mediated 
deadenylation and decapping
Because the RRM 1 domain has been shown to play a 
critical role in mRNA deadenylation (Yao et al. 2007; Lee 
et al. 2010) and UPF1 is known to control mRNA degra­
dation by accelerating both decapping and deadenylation of 
mRNA containing premature codons (Cao and Parker 
2003), we subjected UPF1 to further study. Our reverse 
immunoprecipitation analysis using UPF1 as our bait 
established that RRM1 of PA Bl was required for PABl to 
bind to UPF1. Also, deletion of both the P and C domains 
of PAB 1 did not interfere with UPF1 immunoprecipitating 
PABl and neither the P nor the C domain of PABl was 
required for the ability o f Flag-PABl to bring down UPFl. 
Mammalian studies have indicated that the C-terminal 
domains of PABPC are important to compete presumably 
with UPF1 for binding to translation termination factor 
eRF3 (Brogna and Wen 2009). No such role is likely for 
the combined P and C domains of PABl in yeast given that 
deletion of these two regions of PABl did not affect the 
major part of NMD (Simon and Seraphin 2007).
We further established that the RRM1 domain of PABl 
blocked NMD deadenylation processes but had no effect on 
the more critical NMD-induced decapping process. This 
result is in agreement with recent results that indicate that 
PAB 1 in yeast is not essential for NMD decapping (Mieux 
et al. 2008). Yet, because we have al.so shown that deleting 
the RRM1 domain blocks deadenylation for all processes 
that have been analyzed, as well as for deadenylation in an 
upfl A  background, we cannot necessarily conclude that the 
presumed RRM1-UPF1 interaction that we have identified 
has a specific role for UPF1 function in NMD.
However, one possible role for the RRM1-UPF1 inter­
action was suggested by our results to be in the transition 
from distributive to processive deadenylation by CCR4 that 
occurs in the process of shortening the poly(A) tail. This 
transition naturally occurs following PABl removal from
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the poly(A) tail, usually when the poly(A) tail shortens to 
about 25 A’s (Yao et al. 2007; Ohn et al. 2007; Decker and 
Parker 1993), the minimal size to which PABl binds (Deo 
et al. 1999). This transition is also notably enhanced and 
can occur on even longer poly(A) tail lengths whenever 
deadenylation rates become accelerated, as for the rapid 
deadenylation of normal mRNA (e.g., MFA2), the PUF3 
induction of increased deadenylation of COX17 (Decker 
and Parker 1993; Olivas and Parker 2000; Lee et al. 2010), 
the general augmented rate of deadenylation caused by 
translation initiation defects (Schwartz and Parker 1999), 
and the NMD-induced acceleration of deadenylation 
mediated by UPF1 (Cao and Parker 2003).
Three observations support the RRM1-UPF1 interac­
tion as possibly important to this distributive to proces­
sive transition. First, deleting UPF1 resulted in a shift to 
distributive deadenylation for the PGKI mRNA. Second, 
removal of PABl is a prerequisite for this shift to pro­
cessive deadenylation and deleting the RRM1 domain 
interferes with PABl being removed from the mRNA 
(Yao et al. 2007). Third, under NMD, UPF1 is required 
for the very rapid processive deadenylation that occurs. 
These observations suggest the model that UPF1 accel­
erates deadenylation during NMD by particularly inter­
acting with the RRM1 domain o f PABl and hastening 
removal of PABl from the poly(A) tail. They also 
suggest that UPF1 plays a role in normal mRNA deg­
radation, as previously reported (He and Jacobson 2001; 
Sheth and Parker 2006), by aiding this transition from 
distributive to processive deadenylation. Because the 
factors important to this transition have remained 
unknown, future studies will be required to resolve this 
particular process and the special role of UPF1 in this 
process.
Our identification of the likely domains of PABl to 
which a number of known and novel PABl-interacting 
factors bind indicates that the PABl protein and its mRNP 
structure play diverse roles in the metabolism of mRNA. 
Clearly, it will require an in-depth analysis for each of 
these protein-PABl interactions to illuminate both the 
relevancy of the interaction and its biological role.
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